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Prokaryotes make extensive use of posttranscriptional regulation to modulate 
diverse cellular processes such as central carbon metabolism, stress response pathways, 
and virulence determinants. Posttranscriptional regulation in Escherichia coli is mediated 
via two broadly characterized methods. The first utilizes small noncoding RNAs (sRNAs) 
which bind target mRNA transcripts to alter their stability and translation. Nearly all 
characterized sRNAs function jointly with an RNA chaperone protein, Hfq. The second 
method employs mRNA-binding proteins which directly mediate translational inhibition 
or activation upon mRNA targets. Posttranscriptional regulation by both methods was 
recently demonstrated important to pathogenesis by several bacterial organisms. This 
study addresses the role of posttranscriptional regulation in uropathogenic Escherichia 
coli (UPEC), the organisms responsible for the majority of urinary tract infections. 
Specifically, deletion of Hfq, an RNA chaperone required for many sRNA-mRNA 
interactions, strongly reduced infection in murine models of cystitis and pyelonephritis 
and virtually eliminated formation of UPEC intracellular bacterial communities (IBCs). 
The hfq mutant experienced severe sensitivities to membrane disrupting agents such as 
polymyxin B, reactive oxygen species (ROS) and reactive nitrogen species (RNS) during 
in vitro models of host innate immune function. These phenotypes mirrored those of a 
!E-deleted UPEC, suggesting Hfq’s involvement in posttranscriptional regulation of 
virulence was largely exerted at the bacterial envelope. In addition, RNS-treatment of 
!! "#!
UPEC resulted in posttranscriptional downregulation of CpxP, a periplasmic regulator of 
the Cpx envelope stress response pathway. This downregulation was dependent on 
carbon storage regulator A (CsrA), a protein posttranscriptional regulator, as 
overexpression of CsrB, an sRNA antagonist of CsrA function, was sufficient to prevent 
as well as overcome downregulation of CpxP by RNS. Overexpression of CpxP in the 
presence of RNS proved beneficial to growth, however, suggesting CpxP downregulation 
by urinary RNS may not just disrupt UPEC’s envelope, but impair the Cpx pathway 
involved in its repair. Anti-nitrotyrosine immunoblotting and mass-spectrometry indicate 
nitrosation of CsrA at tyrosine 48, a residue immediately adjacent to the domain 
implicated in RNA interaction, possibly altering CsrA’s binding properties. These results 
demonstrate posttranscriptional regulation assisting virulence, but also imply 
manipulation by the host to deter growth. 
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Worldwide, urinary tract infections (UTI) rank among the most common human 
infections, second only to respiratory infections (1, 2). Strains of uropathogenic 
Escherichia coli are the causative agent of more than 80% of UTIs and also represent a 
significant proportion of nosocomial infections (3, 4). Though not commonly lethal, the 
sheer number of UTIs represent an enormous financial and health burden worldwide (1, 
3). UTIs are strikingly predominant in women, likely attributable to anatomical 
differences such as reduced urethral length and proximity of the urethral meatus to the 
perineum, a possible staging point for infection (5, 6). Moreover, while approximately 
50% of women will experience at least one UTI in their lifetime, the rate of recurrence is 
high, with one in four women having recurrent or relapsing infections (7). Interestingly, 
within individual patients, recurrent infections tend to be caused by UPEC strains that are 
phenotypically and/or genotypically identical to the strain responsible for the initial acute 
infection (8-10). In certain instances, UTI recurrence or relapse with identical strains has 
occurred months-to-years subsequent to the initial infection (11). 
 2 
The incorrigible lifestyle of UPEC 
UPEC have evolved numerous virulence mechanisms that facilitate infection of 
the normally sterile urinary tract (12). As summarized in Fig. 1.1, factors and events 
associated with increased UPEC survival within the urinary tract include, but are not 
limited to, the expression of adhesive organelles, biofilm formation, flagella, and the 
activation of numerous stress response pathways. Crosstalk among host and bacterial 
factors dictates the course of disease, ultimately leading to the eradication or further 
dissemination of the pathogens, or, alternatively, to a sort of détente in which UPEC can 
persist within host tissues for long periods without eliciting overt damage or 
inflammatory reactions.  
Key virulence factors encoded by virtually all UPEC isolates are type 1 pili, 
which are phase-variable polymeric fibrous adhesive organelles expressed on the 
bacterial surface (13, 14). Located at the distal tip of each type 1 pilus is an adhesin, 
FimH, which binds mannosylated glycoprotein receptors on bladder epithelial cells (see 
Fig. 1.1). FimH receptors include uroplakin Ia (UPIa) and !3"1 integrin complexes (15). 
UP1a expression is limited primarily to terminally differentiated bladder epithelial cells 
where it associates with other uroplakin proteins to form hexagonal complexes that coat 
nearly the entire lumenal surface of the bladder (16, 17). !3"1 integrins, on the other 
hand, are more broadly distributed throughout the bladder epithelium and other tissues, 
where they act as key signaling and adherence factors that regulate the formation of focal 
adhesions and other cellular processes (15, 18-20). Binding of FimH initiates a cascade of 
intracellular signaling events culminating in internalization of UPEC via an actin- and 
microtubule-dependent zipper-like mechanism (21) (see Fig. 1.1).  
 3 
Once within a host cell, UPEC may replicate, forming large biofilm-like 
inclusions termed intracellular bacterial communities (IBCs) or “pods” (22-29).  
Alternately, UPEC may remain intracellular, bound within a late endosomal compartment 
in a more quiescent state, or the pathogens may traffic back out of the host cell (20) (see 
Fig. 1.1). Intracellular multiplication of UPEC is seemingly dependent upon the 
abundance of actin within the target host cell. This conclusion is based in part on the 
observation that intracellular bacterial replication occurs rampantly in the actin-poor, 
terminally differentiated superficial bladder epithelial cells, while UPEC growth is 
severely restricted within the immature, actin-rich underlying cells (25) (Fig. 1.1). The 
ability of UPEC to invade and persist quiescently within the immature cells of the bladder 
FIG. 1.1 Overview of UPEC infection in the bladder. UPEC are shown in blue (not to 
scale), terminally differentiated bladder epithelial cells are presented as the large 
hexagonal structures, with small immature bladder cells visible beneath. (1) UPEC 
adhering to bladder epithelial cells via type 1 pili (short rods). Once cellular attachment is 
made, UPEC can invade host cells via a zipper-like mechanism (2). Epithelial cells 
eventually exfoliate in response to infection (3) enabling UPEC to colonize the 
underlying immature cell layers (4). Host defenses such as polymorphonuclear 
leukocytes and nitric oxide (NO, red and blue spheres) (5) help resolve the infection. 
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for many weeks to months may help explain the remarkable predilection for UTIs to 
recur. Quiescent reservoirs of UPEC within immature bladder cells may undergo 
resurgence as the occupied host cells terminally differentiate, a process accompanied by 
dramatic redistribution of cellular actin filaments (25).  
Aggregation of UPEC into biofilm-like communities, including IBCs or 
extracellular aggregates, is known to positively influence the infection process, and 
factors that enhance biofilm formation, such as the autoaggregation surface protein 
antigen 43, improve UPEC persistence in the bladder (30). Aggregation and biofilm 
formation may concentrate nutrients and enable UPEC to better resist antimicrobial 
factors, including antibiotics (31). While sessile activities associated with biofilm 
formation have marked influence on the UPEC infectious cycle, flagella-mediated 
motility has also been shown to confer a competitive advantage. Specifically, motility 
facilitates UPEC ascension into the upper urinary tract, as demonstrated in several studies 
in which flagellated UPEC were observed to have a significant advantage over non-
motile competitors during UTI (24, 32-34).  
Host defenses against UPEC include the presence of high solute concentrations 
within the urine, which are generally inhibitory to bacterial growth, and the generation of 
high shear forces associated by the regular flow of urine, that work to remove non-
adherent or loosely adherent bacteria (35). These largely passive methods of maintaining 
environmental sterility are enhanced by the production of many anti-bacterial 
compounds, including small cationic peptides known as defensins that are capable of 
disrupting bacterial membrane integrity (36), and iron sequestration factors such as 
lactoferrin that deprive invading bacteria of essential iron. Soluble factors such as 
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secretory immunoglobulin A (sIgA) and Tamm-Horsfall protein also bind bacteria, 
preventing adherence to host cells and assisting the removal of microbes from the urinary 
tract with the flow of urine (37, 38). The normally long-lived bladder epithelial cells can 
themselves be sacrificially shed via an apoptotic-like mechanism to facilitate removal of 
bound and internalized bacteria (27, 39, 40). However, bladder cell exfoliation may also 
provide UPEC with access to deeper layers of the bladder epithelium.  
UPEC must also deal with infiltrating neutrophils and other immune effector cells 
that act to eliminate pathogens by phagocytosis and by the release of numerous anti-
bacterial compounds, including reactive nitrogen species (RNS) and reactive oxygen 
species (ROS) (Fig. 1.1.5). RNS and ROS can covalently modify and damage lipids, 
proteins, and nucleic acids (RNA and DNA), disrupting components both within the 
bacterial cytosol as well as the bacterial envelope, including the inner and outer 
membranes and the intervening periplasmic space (26, 41-44). Additional sources of 
RNS and ROS include bladder epithelial cells, which contribute RNS during the course 
of a UTI (45) and UPEC themselves under anaerobic or microaerophilic conditions where 
RNS forms as a metabolic by-product during reduction of abundant urinary nitrate to 
nitrite (46). Nitrite itself is also a reactive end product of nitric oxide (NO) generation. 
Urine nitrite levels, which can exceed 500 !M, are frequently used as a diagnostic 
indicator of UTI (46).  Of note, UPEC isolates are often able to resist RNS levels that 
prevent growth of standard laboratory E. coli K12 strains (44, 47, 48). 
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Nitrosative stress responses 
E. coli and other bacterial species employ multiple oxidative and nitrostive stress 
sensing and response systems. Among these is the prototypical SOS stress response 
pathway, which is activated by DNA damage caused by various agents, including oxygen 
radicals and RNS such as S-nitrosothiols (49). Interestingly, the SOS response can also 
be activated by polyamine compounds (50, 51), and polyamines such as cadaverine can 
enhance the resistance of UPEC to RNS (47, 52). Multiple redox-sensitive pathways and 
factors, such as the transcriptional regulators SoxR, OxyR, and NorR, recognize and 
respond to oxidative and nitrosative stresses by upregulating flavorubredoxins, 
oxidoreductases, iron-transporters and catalases, which act to detoxify nitrosative and 
oxidative radicals (53-59). Virtually all of the RNS- and ROS-responsive systems 
described to date are cytosolicly localized. 
The bacterial envelope represents the principle interface between a bacterium and 
its environment. It is here that early detection of, and first responses to, environmental 
and host-generated stresses are most likely to occur. Due to the highly ionic nature of 
many RNS and ROS, the bacterial envelope is only variably permeable to these radicals. 
RNS- and ROS-mediated damage to lipids and proteins within the envelope is therefore 
are plausible, especially in the face of host inflammatory responses. Considering these 
facts, I hypothesized that one of the earliest bacterial responses to nitrosative stress is 
activation of envelope stress response pathways. 
To address this hypothesis I generated short-lived GFP promoter fusion reporter 
constructs to assess activation of a canonical envelope stress response pathway, the Cpx 
system (Fig. 1.2). This system is composed of three principle components: the integral 
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inner-membrane histidine kinase CpxA; the cytosolic transcription factor CpxR; and the 
periplasmic adaptor CpxP. Under noninducing conditions, CpxP binds to the periplasmic 
region of CpxA, keeping CpxA in an inactive state. Under inducing stresses, such as the 
generation of misfolded pilin subunits within the periplasm, alkaline pH, and/or bacterial 
adherence to abiotic surfaces, CpxP dissociates from CpxA, allowing CpxA to 
phosphorylate the cytosolic response regulator CpxR. Once phosphorylated, CpxR can 
mediate transcriptional activation or repression of a broad set of genes including 
periplasmic disulfide bond catalysts, isomerases, chaperones, and proteases (60). CpxA, 
R, and P are also all upregulated downstream of Cpx pathway activation, although only 
FIG. 1.2. Schematic representation of Cpx pathway activation. Misfolded periplasmic 
proteins (squiggly lines) cause the periplasmic adaptor protein, CpxP, to dissociate from 
the sensor-kinase CpxA, resulting in CpxA activation and subsequent phosphorylation of 
the response regulator CpxR. Acting as a transcription factor, CpxR modulates the 
expression of over 100 genes, including cpxP. As periplasmic stress is alleviated, CpxP 
binds once again binds and inhibits CpxA as part of an autoinhibitory mechanism. 
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CpxP expression is entirely dependent upon the CpxR transcription factor (46). Because 
of this last property, CpxP reporter constructs are often used as sensitive indicators of 
Cpx activation (61, 62). Using a similar approach, I exploited a cpxP promoter fusion to 
assess activation of the Cpx pathway in response to nitrosative stress, with the hypothesis 
that RNS would induce misfolding of periplasmic proteins. 
Chapter 2 of this dissertation describes results from my study of the Cpx pathway 
in UPEC under nitrosative stress. Using Cpx reporter constructs, I demonstrate the proper 
induction of these reporters under Cpx-inducing conditions, but also observed that, 
contrary to my hypothesis, CpxP expression under nitrosative stress was completely 
abolished. Notably, RNS-mediated repression of other Cpx gene products, aside from 
CpxP, was not observed. RT-PCR and microarray analysis indicated that repression of 
CpxP expression in response to RNS occurred via a  posttranscriptional mechanism. 
Coincident with the ablation of CpxP expression, I also observed massive upregulation of 
several cytosolic nitrosative stress response genes and multiple genes associated with 
motility. These results indicate potentially important functional links among the Cpx 
system, nitrosative stress responses, motility, and posttranscriptional regulators of gene 
expression in UPEC. 
Posttranscriptional regulation in E.coli 
In assessing potential mechanisms for the posttranscriptional control of CpxP 
expression in the presence of RNS, I became intrigued with the general mechanisms of 
posttranscriptional regulation (PTR) in bacteria. In particular, how do pathogens employ 
PTR to modulate virulence? In UPEC, what specific virulence determinants are regulated 
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by PTR and what are the functional consequences of this regulation? These questions 
form the core of what this dissertation addresses. 
Several PTR mechanisms have been well characterized in E.coli and related 
species. These mechanisms fall broadly into two categories: 1) those involving 
interactions between regulatory proteins like CsrA with target mRNAs and 2) those 
where small noncoding RNAs (sRNAs) interact with specific mRNA transcripts. Both 
cases may involve translational repression or activation and may also affect message 
stability. Translational repression can result from occlusion of the Shine/Dalgarno 
sequence, abrogating ribosome binding. Conversely, posttranscriptional regulatory 
factors may promote relaxation of secondary structures within target transcripts, opening 
up ribosome binding sites, thereby promoting translation. Alterations to message stability 
occur when Hfq, in conjunction with sRNAs, protects or reveals RNase degradation sites 
within the mRNA (see reviews (63-66)). 
Protein-based posttranscriptional regulation: CsrA 
The PTR factor carbon storage regulator A, or CsrA, is a global regulator of 
glycogen biosynthesis and central carbon metabolism in E. coli, with noted homologs 
extending to Gram-positive organisms (67-70). CsrA is capable of translational 
activation, RNA stabilization, and translational inhibition, mediated by CsrA interactions 
with consensus ruACArGGAuGU motifs in target transcripts (71). CsrA can have broad 
effects leading, for example, to increased stabilization and/or translation of mRNA 
transcripts associated with glycolysis and the glyoxalate shunt (69, 72), acetyl-coenzyme 
A synthesis (73), and the flhDC master regulator of motility (74). Alternately, CsrA can 
downregulate metabolic processes such glycogen synthesis and gluconeogenesis (69, 75, 
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76). Furthermore in several Gram-negative bacterial pathogens CsrA regulates virulence 
determinants such as biofilm production (77, 78) and attachment (78), extracellular 
amyloid-fibrils termed curli (79), and motility (46). The ability of CsrA to regulate 
virulence determinants and carbon metabolism along with biofilm formation and motility 
has prompted speculation that this posttranscriptional regulator acts to modulate key 
physiological changes in bacterial pathogens as they switch from acute to 
chronic/persistent phases of an infection cycle (80). 
Interestingly, CsrA activity is itself posttranscriptionally regulated, with two 
genomically-encoded sRNAs, CsrB and CsrC, acting as antagonists (81, 82). Both 
sRNAs are almost entirely composed of variable CsrA-binding sites, with the 
stoichiometry of CsrB-to-CsrA binding calculated at 18:1 (83). These binding sites are 
believed to serve as molecular decoys to titrate CsrA dimers away from target transcripts. 
CsrB and CsrC are activated by the transcriptional regulator UvrY, a component of the 
BarA-UvrY two-component system  that respond to glucose and the glycolytic end-
products acetate and formate (84-86). An autoinhibitory loop is formed as CsrA induces 
glycolysis, producing acetate and formate, which results in activation of UvrY and 
increased production of the CsrB sRNA (81). 
Noting the large upregulation of motility-associated genes concomitant to 
posttranscriptional downregulation of CpxP under nitrosative stress, I hypothesized that 
posttranscriptional regulator CsrA may be responsible. This possibility was tested, as 
described in Chapter 2, by inducing overexpression of the CsrA antagonist CsrB. These 
experiments demonstrate that antagonization of CsrA function is sufficient to alleviate 
CpxP repression under nitrosative stress. To investigate the possibility of CsrA binding 
 11 
the cpxP leader region, I determined the 5’ untranslated region (UTR) of the cpxP 
transcript. Within the 5’ UTR is a region with some homology to the known CsrA-
binding consensus. I hypothesize that modification of CsrA or one or more of its targets 
in the presence of RNS leads to repression of CpxP translation. Key amino acid residues 
affected by RNS include cysteines and tyrosines. CsrA lacks cysteines, but contains two 
conserved tyrosine residues, Tyr48 and Tyr61. Immunoblots using nitrotyrosine-specific 
antibody and tandem mass-spectrometry of purified, RNS-treated CsrA indicated that 
Tyr48 of CsrA could be nitrated. Tyr48 is adjacent to Ile47, a residue shown to be critical 
to the ability of CsrA to bind RNA targets (87). In silico analyses indicate nitration of 
Tyr48 would introduce substantial steric hindrance within an alpha-helix containing 
Ile47, possibly altering the RNA-binding properties of CsrA. This may represent a 
mechanism whereby the binding specificity of CsrA may be altered, and may contribute 
to the posttranscriptional repression of CpxP expression under nitrosative stress. 
The ability of RNS to cause posttranscriptional downregulation of CpxP raised 
the question of whether this phenomenon was beneficial or detrimental to UPEC. In in 
vitro assays, I found that overexpression of CpxP in UPEC in the presence of RNS 
enhanced the growth of UPEC, while a cpxP null mutant grew similar to the wild type 
strain. These results suggested that CpxP levels were modulatory, rather than essential, to 
UPEC survival and growth in the presence of RNS. However, in a murine model of 
cystitis, the cpxP null mutant was significantly less fit than the parent wild type strain, at 
least in competition assays. Of note, cpxR and cpxA null mutants were similarly 
disadvantaged in vivo in competition assays. These data indicate that the Cpx system can 
assist growth in the murine urinary tract or in nitrosative stress conditions. This implies 
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that the downregulation of CpxP by RNS may be a host mechanism to disrupt a canonical 
bacterial envelope stress response pathway, thereby inhibiting the infection process. This 
conclusion, however, remains open to interpretation since RNS-mediated attenuation of 
CpxP expression may have alternate outcomes under varying environmental conditions. 
One particularly intriguing possibility is that RNS generated by UPEC themselves may 
be employed as a means to posttranscriptionally regulate the Cpx system.  
Small-noncoding RNAs and the RNA chaperone Hfq 
The second class of PTR employs sRNA base-pairing with mRNA transcripts to 
facilitate translational activation, repression and/or to alter message stability. These base-
pairing interactions often occur through multiple, nonadjacent regions of 2-8bp (88, 89). 
sRNAs may inhibit translation by blocking the ribosome binding site (RBS) within the 
5’-UTR. A prime example of this is the OxyS sRNA , which binds and inhibits 
translation of flhA mRNA (90). Activation of translation can occur when an sRNA 
disrupts an incipient auto-inhibitory RNA duplex in the 5’ leader region of a transcript, 
such as occurs with the RprA and DsrA sRNAs as they interact with transcripts encoding 
the stationary-phase sigma factor RpoS (91-94). sRNAs may also affect translation of 
multiple targets. For example, DsrA not only activates translation of rpoS transcripts, but 
also represses translation of hns transcripts, which code for a histone-like protein (95, 
96). Analysis of the differential binding and action of DsrA on the rpoS and hns 
tanscripts revealed that DsrA could assume multiple conformations for achieving 
different base-pairing interactions with its targets (95, 96). sRNAs are genomically 
encoded and transcribed normally from individual promoters, typically resolving in a rho-
independent terminator (89). Although most sRNAs are unique genes with independent 
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promoters, at least one sRNA, SgrS, exists that is derived from an existing mRNA, 
transcribed opposite of the protein coding strand, (97). 
Of all the confirmed sRNAs in the literature, over half require a protein co-factor, 
Hfq, to mediate their effects. Hfq, which is highly conserved amongst bacteria and 
archaea, was originally characterized as a host factor required for Q" phage replication 
(98, 99).  Forming homohexameric complexes, Hfq has noted structural similarity to 
eukaryotic Sm-like proteins that are involved in RNA splicing (100-103). Hfq non-
specifically binds RNAs at A/U-rich sites (104), facilitating interactions between mRNAs 
and sRNAs (105). Hfq is involved in the pathogenesis of many organisms, including 
Brucella abortus (106), Pseudomonas aeruginosa (107), Listeria monocytogenes (108), 
FIG. 1.3. Hfq is involved in regulation of !S and !E. Hfq, shown in green, assists 
sRNA (shown in cyan) in interactions governing translation of the rpoS gene, coding for 
the "S transcription factor. Deletion of hfq results in constitutive activation of the 
periplasmic degradation factor DegS which degrades RseA and RseB leading to 
constitutive activation of "E. 
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Vibro cholerae (109), Legionella pneumophila (110), and Salmonella typhimurium (111), 
although it is dispensable for infection by the Gram-positive Staphylococcus auerus 
(112). In K12 laboratory E. coli strains, Hfq acts as a pleiotropic regulator (113), 
controlling the expression of at least two major bacterial sigma transcription factors (see 
Fig. 1.3). The stationary-phase or general stress-response sigma factor "S, encoded by the 
rpoS gene, is regulated by three Hfq-dependent sRNAs: DsrA, RprA, and OxyS (114). "S 
assists bacterial adaptation to oxidative, hyperosmotic, pH, nutritional, and UV radiation 
stresses (115). Many phenotypes associated with hfq deletion have previously been 
attributed to effects on RpoS expression (116). Hfq is also involved in the regulation of 
rpoE, which encodes the envelope stress sigma factor "E (109, 111, 117-120). Loss of hfq 
results indirectly in constitutive activation of the "E regulon due to upregulation of the 
periplasmic protease DegS, which degrades the the "E sequestration factor RseA (111). 
An hfq mutant may thus be anticipated to have phenotypes resulting from effects on 
either the "S or the "E stress response pathways. 
Control of message stability and translation by sRNAs represents a potentially 
fast-acting method for modifying protein and mRNA levels, permitting highly specific 
fine-tuning of gene expression above and beyond transcriptional control. sRNAs tend to 
be degraded with their mRNA interaction partners, providing an auto-inhibitory 
mechanism, and further assisting energetic efficiency in the bacterium. Energy- and time-
intensive translation is not required for sRNAs to function, enabling them to be produced 
and act rapidly. In this respect, sRNAs function ideally as rapid response systems, and 
have been found, not surprisingly, to regulate many stress-response and bacterial 
envelope proteins. Indeed, approximately half of the known Hfq-dependent sRNAs 
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characterized affect translation of envelope proteins. The OmrA/OmrB sRNAs regulates 
curli expression by directly interacting with the RBS of the csgD transcript (121). Porins 
or outer membrane proteins (OMPs), the predominant envelope proteins, are frequently 
the target of sRNA regulation (122-125). For example, expression of the highly abundant 
OMP, OmpA, is regulated by the sRNA MicA (126-128), while OmpC is controlled by 
the sRNA OmpW (118), OmpF by the sRNA MicF (129-131), and YbfM, an OMP of 
unknown function, by the sRNA MicM/RybB/SroB (132). These porins tend to be beta-
barrel structures believed to function as solute channels through the outer membrane, 
although several also serve as phage receptors (133). At least two of these sRNAs, MicA 
and RybB, also fall under control of the #E transcriptional regulator (118). In addition, at 
least one two-component signal transduction system, the PhoPQ pathway, which 
responds to low-levels of extracellular divalent cations, is translationally regulated by the 
sRNA MicA (134). 
After addressing the involvement of the protein-mediated class of 
posttranscriptional regulation in UPEC, as exemplified by CsrA, I turned my attention to 
the possible involvement of sRNAs as mediators of UPEC fitness and virulence. To 
broadly test the role of sRNAs in UPEC pathogenesis, I deleted hfq from a reference 
UPEC isolate (UTI89) and tested its fitness and virulence potential in a range of in vivo 
and in vitro assays, as described in Chapter 3. Although the UPEC hfq mutant grew 
normally during in vitro growth analyses, it was highly defective in bladder colonization 
and completely unable to colonize the kidneys. In addition, the hfq mutant was virtually 
incapable of forming IBCs. These experiments indicate the necessity of Hfq, and hence, 
sRNAs during the infection process. 
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How does Hfq, and thus sRNAs, influence UPEC virulence? These observed 
defects in infection in vivo could be attributable to disregulation of many specific 
virulence determinants, including disruption of envelope integrity, improper expression 
of the #S response regulator, and/or the disturbance of one or more stress response 
pathways.  As detailed in Chapter 3, in vitro assays indicate that disruption of hfq in 
UPEC has diverse pleiotropic effects, leading to decreased biofilm formation, reduced 
motility, and increased bacterial susceptibility to RNS, ROS, and envelope-disrupting 
cationic peptides like polymyxin B. Considering the impact that Hfq has on #E and #S, 
the phenotypic comparisons were made among hfq, rpoS (#S) and rpoErseABC (#E) 
deletion mutants. Although I observed some phenotypic overlap among these mutants, 
the hfq mutant was dramatically more sensitive to polymyxin B and RNS, indicating 
observed phenotypes associated with disruption of hfq were not solely due to 
disregulation of #E and #S. Moreover, the hfq mutant uniquely exhibited highly altered 
lipopolysaccharide, the predominant surface molecules. In total, these results demonstrate 
the importance of Hfq to UPEC infection, while highlighting the distinct contribution that 
Hfq has on bacterial phenotypes independent of the #S and #E stress response systems.  
Summary 
Taken together, the data presented in this thesis begin to delineate the critical 
importance of PTR in regulating the fitness and virulence potential of UPEC. The 
protein-mediated arm of PTR, CsrA, downregulates CpxP expression under nitrosative 
stress, which in turn may have direct bearing on the fitness of UPEC within the host.  
Although this work only begins to address indirectly the contribution of CsrA to UPEC 
 17 
virulence, the results suggest that this posttranscriptional regulator will be a central player 
in the pathogenesis of UTIs. The pleiotropic effects of Hfq on UPEC virulence and 
fitness within the host and in in vitro assays likewise highlight the critical involvement of 
sRNAs as important virulence factors with wide-ranging targets.  Cumulatively, this 
work demonstrates that PTR can vitally impact UPEC virulence mechanisms, suggesting 
novel means by which these pathogens can sense and respond to the numerous stresses 
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OF THE CPX PATHWAY IN UROPATHOGENIC
ESCHERICHIA  COLI UNDER
NITROSATIVE STRESS
Abstract
During the course of a urinary  tract infection, strains of uropathogenic 
Escherichia coli (UPEC) can elicit a number of host inflammatory responses, including 
the production of reactive nitrogen species (RNS). These radicals can react with and 
damage membrane proteins and other components of the bacterial envelope, potentially 
affecting envelope stress response pathways. To address this possibility, I employed 
promoter-fusion reporter constructs to assess activation of the Cpx two-component 
envelope stress response system. I found that exposure of UPEC to RNS generated by 
acidified sodium nitrite (ASN) abrogated expression of a key Cpx regulon member, 
CpxP, by  a posttranscriptional mechanism involving the global regulator CsrA. In vitro 
growth assays as well as in vivo competition experiments using a murine infection model 
indicated that the Cpx system, including CpxP, can positively affect the fitness of UPEC 
in the face of RNS and other stresses encountered within the host environment. In total, 
31
these data indicate that RNS-mediated attenuation of CpxP expression via CsrA may 
factor in as a host defense within the urinary tract and at other sites of infection, but this 
phenomenon may also represent a mechanism by which bacteria themselves can 
modulate the Cpx system through the generation of endogenous RNS. 
Introduction
Urinary tract infections (UTIs), which include cystitis and pyelonephritis, 
currently rank among the most common of infectious diseases within the human 
population (1). The vast majority of UTIs are caused by  strains of uropathogenic 
Escherichia coli (UPEC) that can bind and invade host cells within the urinary  tract (2, 
3). The infection process can stimulate a number of antimicrobial and proinflammatory 
host responses, including the generation of nitric oxide (NO) and other reactive nitrogen 
species (RNS). Nitrite (NO2!) is a significant RNS present during a UTI, reaching 
concentrations in excess of 500 µM in the urine of infected patients (4). The activity of 
host nitric oxide synthases, as well as nitrate-reducing uropathogenic bacteria like UPEC, 
are likely sources of nitrite within the urinary  tract during a UTI (5-7). Acidification of 
nitrite in low pH environments can result in formation of additional RNS, including nitric 
oxide (NO), nitrogen dioxide (NO2), and nitrous acid (HNO2) (8, 9). In the lab, acidified 
sodium nitrite (ASN) is a widely  used system for generating RNS in vitro. During the 
course of a UTI, RNS like those produced via ASN are thought to contribute to the 
antibacterial characteristics of urine (4). 
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RNS damage nucleic acids, lipids, and proteins and can inactivate or alter 
enzymatic processes, metabolic pathways, and signal transduction cascades (10-16). In 
Gram-negative bacteria, RNS have been shown to stimulate a number of cytoplasmic 
stress responses, including the SOS pathway (17, 18), the OxyR transcription factor (19, 
20), and the SoxRS two-component regulatory system (21). RNS effects on the bacterial 
envelope, which in Gram-negative bacteria is comprised of an inner and outer membrane 
and the intervening periplasmic space, are less well defined. 
The bacterial envelope interfaces with the external environment and functions as a 
selectively permeable physical barrier. Recent work using atomic force microscopy 
indicates that exposure of E. coli to NO can severely  compromise the integrity  of the 
envelope (22). By  reacting with and damaging components of the bacterial envelope, 
RNS may  trigger the activation of stress response pathways that specifically  recognize 
and respond to envelope stress. In UPEC and in other E. coli strains, envelope stress is 
sensed by one or more of several identified systems: these include the "! and Rcs 
pathways along with the BaeSR and Cpx two-component systems (23-25). 
The Cpx system is comprised of the inner membrane histidine kinase CpxA and 
the cytoplasmic response regulator CpxR (26). In response to envelope stress CpxA 
phosphorylates CpxR, which then functions as a transcriptional regulator. CpxR controls 
the expression of protein folding and degrading factors involved in relieving envelope 
stress and can also regulate biofilm formation (27, 28), bacterial adherence (27, 29, 30), 
motility and chemotaxis (31), type III and type IV secretion systems (32-36), and, 
potentially, bacterial toxins such as #-hemolysin and cytotoxic necrotizing factor 1 (29, 
32
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37). Data from Lin and co-workers have suggested that CpxR can directly control nearly 
100 genes in the E. coli K12 reference strain MG1655 (38). CpxR appears to have a key 
role in regulating virulence in a number of pathogens (23), including Salmonella species 
(39, 40), Legionella pneumophilia (32), Shigella sonnei (34-36), enteropathogenic E. coli 
(33), Actinobacillus suis (41), Haemophilus ducreyi (42), Xenorhabdus nematophila (43), 
Yersinia pseudotuberculosis (44), and potentially UPEC (29, 30, 45). 
In E. coli and other microbes the Cpx system is subject to negative feedback 
through CpxP, a small CpxR-regulated periplasmic protein that is proposed to bind the 
sensor kinase CpxA, keeping it in an inactive state (26, 46). CpxP is the most highly 
inducible member of the Cpx regulon so far identified and has elevated expression in 
response to both envelope stress and entry into stationary phase growth (46, 47). In 
addition to its role as a negative regulator of CpxA, CpxP also functions as an adaptor 
protein, interacting with a subset of misfolded periplasmic proteins and delivering them 
to the protease DegP for degradation (48, 49). In this process, CpxP is degraded along 
with its misfolded substrate, suggesting a mechanism by which bacteria can post-
translationally  modulate CpxP levels. To date, stimuli that explicitly  inhibit CpxP 
expression have not been reported. 
Here, I sought to determine if RNS, which are generated in copious amounts 
during the course of a UTI, could influence the Cpx pathway. my results reveal an 
unexpected mechanism whereby nitrosative stress represses CpxP expression in a 
posttranscriptional manner involving the global regulatory factor CsrA (Carbon Storage 
Regulator). Possible consequences of this inhibitory  pathway are discussed in light of 
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data showing for the first  time that CpxP, as well as CpxR and CpxA, significantly 
enhance the fitness of UPEC within the urinary tract.
Results
Cpx reporter constructs
The cpxRA operon and cpxP are separated on the E. coli chromosome by  a well-
conserved 146 bp segment containing two putative CpxR binding sites (Fig. 2.1.a). CpxP 
is among the most highly inducible members of the Cpx regulon, and in E. coli K12 
strains the transcription of cpxP is almost entirely dependent upon CpxR (47, 50). To 
assess RNS effects on the Cpx stress response system, I created a transcriptional fusion 
using the 146 bp intergenic region upstream of the cpxP start site linked to a reporter 
gene encoding a destabilized variant of Green Fluorescent Protein (GFP-ASV). In E. coli, 
this GFP variant  has a half-life of approximately 120 min (51), allowing us to follow 
expression levels of this reporter with a fine degree of temporal resolution. 
The cpxP-GFP reporter construct (pJLJ5) was transformed into the human cystitis 
isolate UTI89, and in control experiments was shown to be responsive to stimuli known 
to activate the Cpx pathway. Specifically, GFP-ASV expression under control of the cpxP 
promoter was elevated in response to overexpression of either the PapE pilin subunit or 
the outer membrane lipoprotein NlpE, as determined by Western blot analyses (data not 
shown and Fig. 2.2.a). Expression of cpxP-GFP was not observed in a mutant lacking 
cpxR (Fig. 2.1.b). As expected of CpxP itself (31, 47), expression of the cpxP-GFP 
reporter was also increased as UTI89/pJLJ5 entered into late log-phase growth (see 
34
35  35
FIG. 2.1. The Cpx gene cluster and CpxR-dependent expression of the cpxP-GFP 
reporter. (A) Organization of the cpx genes, with the 146 bp  intergenic region from 
which cpxRA and cpxP are divergergently  transcribed shown in detail. Potential CpxR 
binding sites are shown in sky  blue boxes, while the orange-shaded region indicates the 
putatitive 5’-UTR for cpxP. (B) Image shows Western blots, probed with anti-GFP 
antibody, used to examine the expression of cpxP-GFP (pJLJ5) and cpxR-GFP (pJLJ10) 
reporters in late log-phase cultures (=0.8) of wild-type UTI89 and an isogenic cpxR 
knockout mutant.
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FIG 2.2. PapE overexpression counters ASN effects on CpxP expression. Western 
blots probed with anti-GFP antibody were used to detect expression of the cpxP-GFP 
reporter (pJLJ5) with or without IPTG-mediated induction of PapE expression (pHJ13) ± 
the addition of 1 mM ASN. (A) IPTG was added, as indicated, to induce PapE expression 
coordinate with 1 mM ASN at  the 1 h time point, leading to enhanced cpxP-GFP 
expression. All images shown were obtained from a single blot using equivalent 
exposure. (B) ASN was added to cultures at the 1 h time point, while the addition of 
IPTG for induction of PapE expression was delayed until the 5 h time point. These 
experiments were repeated at least three times with similar results.
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controls in Fig. 2.3.b). Reversing the orientation of the 146 bp cpxP promoter region in 
front of gfp-ASV created a putative cpxR reporter construct (pJLJ10), which served as an 
additional control in these studies. Expression of cpxR-GFP was only slightly diminished 
in the $cpxR mutant (Fig. 2.1.b), consistent with previous observations showing that, in 
contrast to cpxP, cpxR transcription itself is just partially  regulated by  CpxR. GFP 
expression was not detected under any of the tested conditions in UTI89 carrying a 
promoterless-GFP construct (pJLJ1, data not shown). Of note, for comparative analysis 
of Western blots in this study, I used equivalent film exposure times and ensured that 
equal amounts of protein from each sample were loaded onto the gels as appropriate (see 
Experimental Procedures). 
RNS effects on CpxP expression
To assess the effects of nitrosative stress on the Cpx pathway, overnight cultures 
of the recombinant UTI89 strains grown in MES-buffered LB broth (MES-LB, pH 5) 
were diluted into fresh media and grown shaking for 1 h prior to the addition of 1 mM 
ASN to generate RNS. Exposure to ASN markedly  slowed the growth of the bacteria and 
caused them to enter stationary phase at a lower density (Fig. 2.3.a). As anticipated, 
CpxP expression, as monitored using the cpxP-GFP reporter construct, was induced as 
UTI89 entered late log-phase growth in the absence of ASN (Fig. 2.3.b). However, in 
contrast to my predictions, CpxP expression in the presence of ASN was completely 
abolished. Under the same conditions, CpxR expression, as discerned using the cpxR-
GFP reporter construct, was not notably affected by the presence of ASN (Fig. 2.3.c). 
Expression levels of GFP-ASV driven by  a lac promoter were also unfazed by ASN (data 
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FIG. 2.3. Growth of UPEC in the presence of RNS abrogates CpxP expression. (A) 
Growth curves of UTI89/pJLJ5 (cpxP-GFP reporter) grown shaking in broth ± 1 mM 
ASN, which was added at  the 1 h time point (thick arrow). (B) Western blots, probed 
using anti-GFP antibody, show levels of cpxP-GFP expression over time in UTI89/pJLJ5 
± ASN. (C) Western blots showing levels of the cpxR-GFP reporter in UTI89/pJLJ10 
during growth ± ASN. These experiments were repeated three or more times with similar 
results.
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not shown). Thus, loss of GFP-ASV expression by bacteria carrying the cpxP-GFP 
reporter was not simply due to enhanced proteolysis of GFP-ASV upon exposure to ASN. 
Rather, ASN had a seemingly specific inhibitory effect on expression of the cpxP-GFP 
promoter fusion.  
Once inhibited by exposure to ASN, expression of the CpxP did not recover for up 
to 24 h later (data not shown).  However, forced expression of PapE, a strong inducer of 
Cpx activation (52), was able to prevent complete abrogation of CpxP expression in the 
presence of ASN (Fig. 2.2.a), and could even resurrect CpxP expression at late time 
points following exposure to ASN (Fig. 2.2.b).  Overexpression of another potent inducer 
of the Cpx pathway, NlpE (53), had a similar antagonistic effect (data not shown), 
indicating that ASN-mediated downregulation of CpxP expression can in effect be 
overridden under some conditions if the Cpx pathway is sufficiently activated by other 
stimuli. 
Growth phase- and RelA-dependent effects on CpxP
expression in the presence of RNS
While exposure of early growth phase UTI89 cultures to ASN had a profound and 
lasting inhibitory effect on CpxP expression, the addition of ASN to mid-log or stationary 
phase cultures was seemingly inconsequential (Fig. 2.4). Coincident with bacterial entry 
into stationary phase is the accumulation of the alarmone guanosine tetraphosphate 
(ppGpp), a global transcriptional regulator that is synthesized by the relA gene product 
(54). As amino acids are depleted, increased ppGpp levels can drastically  alter the 
transcriptional profile of the bacterial cell as part of the stringent response, diminishing 
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FIG 2.4. ASN effects on CpxP expression are limited in stationary phase cultures. 
(A) Representative growth curves of UTI89/pJLJ5 grown shaking in MES-LB in the 
presence (dotted line) or absence (solid line) of 1 mM  ASN, which was added at the 8 h 
time point (arrow). (B) Western blots using anti-GFP antibody show expression of the 
cpxP-GFP reporter in the stationary phase cultures ± ASN. These experiments were 
repeated three times with similar results.
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FIG. 2.5. RelA and CpxA effects on CpxP expression in UTI89. (A) Curves show 
growth of UTI89/pJLJ5 (cpxP-GFP reporter) carrying either pRelA (for IPTG-inducible 
expression of RelA) or the empty vector control pMMB66EH. ASN was added to the 
indicated cultures (dotted lines) at the 1 h time point, while IPTG was added to all 
samples at 2 h. (B) Westen blots probed with anti-GFP antibody showing levels of cpxP-
GFP expression at hourly  time points in the samples indicated in (A). (C) Western blots 
showing levels of cpxP-GFP expression over time in wild-type UTI89 versus an isogenic 
$cpxA mutant, either without (empty vector control) or with (pRelA) overexpression of 
RelA, which was induced at the 2 h time point. Results shown are representative of 
experiments repeated at least three times.
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the expression of genes required for growth and proliferation while activating many 
genes involved in virulence and survival pathways (55). To test the capacity ppGpp levels 
to affect the Cpx pathway, and specifically ASN-mediated downregulation of CpxP, I 
employed an IPTG-inducible RelA expression construct (56). Overexpression of RelA 
drove UTI89 to enter stationary phase growth early (Fig. 2.5.a), and stimulated cpxP-
GFP expression by  as much as four fold over controls (Fig. 2.5.b). However, induced 
expression of RelA did not overcome the inhibitory effects of ASN on CpxP expression.
CsrA-mediated downregulation of CpxP by RNS
Semiquantitative reverse-transcription PCR (RT-PCR) was performed to assess 
cpxP message levels in UTI89 cultures grown to late log-phase (=0.8) in the presence or 
absence of 1 mM ASN. Amplification of 16S RNA served as a positive control in these 
assays. As shown in Figure 2.6.a, growth in ASN had little effect on transcription of 
either native cpxP or 16S RNA. Message levels of the cpxP-GFP promoter fusion was 
similarly  unaffected by ASN, while cpxR was slightly  elevated. These data indicate that 
ASN-mediated downregulation of CpxP expression likely occurs via a posttranscriptional 
mechanism. 
Microarray analysis of UTI89 cultures grown to OD600=0.8 with or without ASN 
present corroborated these results, indicating that cpxP, cpxR, cpxA, and 16S RNA 
expression changed in response to ASN by  only  0.84-, 1.45-, 1.50-, and 0.9-fold, 
respectively. In sharp contrast, the expression of many genes like norV, narK, yeaR, 
yoaG, which are known to be responsive to nitrosative stress based on previous work 
from my lab and others (57-61), were massively  upregulated by growth of UTI89 in 
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ASN, with some being activated by greater than 1,000-fold. A summary of the top 100 
most highly expressed genes according to functional category is presented in Fig. 2.6.b, 
and the genes represented in this graph are listed in Table 2.3. Nearly half of these genes 
(colored blue in Fig. 2.6.b) are involved in bacterial motility, and can be positively 
controlled either directly or indirectly by a master regulator of motility, the multimeric 
DNA-binding FlhDC protein complex (62).
By microarray analysis, expression levels of the genes encoding FlhDC were 
found to be upregulated about two-fold in the presence of ASN. As with other 
transcriptional regulators, even small changes in the abundance of FlhDC can potentially 
have sizeable effects on the expression of FlhDC-regulated genes (63). The flhDC 
transcript is bound and stabilized by CsrA, a global regulatory  protein (64). CsrA is 
antagonized by  two small noncoding RNA (sRNA) CsrB and CsrC, which sequester and 
thereby inactivate multiple CsrA homodimers (65, 66). Expression of CsrB is controlled 
by the BarA-UvrY two-component system, which itself is regulated by  CsrA as part of an 
autoregulatory circuit (67). Recently, the BarA sensor kinase was shown to be responsive 
to formate and acetate, end products of glucose metabolism that can accumulate in 
growth media as bacteria transition into stationary phase (68). 
CsrA recognizes consensus binding sites in the 5’-untranslated region (UTR) of 
many transcripts and can either activate, as in the case of flhDC, or inhibit translation of 
these target messages (64, 69). The remarkable induction of FlhDC-regulated genes in 
UTI89 in the presence of ASN (Fig. 2.6.b) suggested the potential involvement of CsrA, 
which I hypothesized could also negatively affect cpxP translation in my  assays. As 
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FIG. 2.6. Posttranscriptional control of CpxP expression by CsrA in the presence of 
ASN. (A) RT-PCR was performed on total RNA isolated from UTI89/pJLJ5 cultures 
grown to OD600=0.8 ± 1 mM ASN and primers specific for cpxR, cpxP, gfp, and 16S 
RNA. Mean integrated intensity  rations of RT-PCR products from the ASN-treated versus 
nontreated samples (+ASN/-ASN) are shown, 1.0 indicating no difference in transcript 
levels between the +ASN and –ASN samples. (B) Pie-chart showing the top 100 
upregulated genes in UTI89 grown to OD600=0.8 in the presence of 1 mM  ASN, as 
assessed by  Affymetrix E.coli 2.0 microarrays. Genes were sorted and color-coded by 
category, as indicated on the right. The outer bars in the graph represent fold-change 
differences between the ASN-treated and nontreated samples, shown on a log10 scale. (C) 
Western blot analysis of cpxP-GFP expression in UTI89/pJLJ5 grown in the presence of 1 
mM ASN, with glucose added at the 7 h. (D) Western blots show cpxP-GFP expression in 
UTI89/pJLJ5 carrying either an empty vector control (pRRK1) or the IPTG-inducible 
CsrB expression construct pRRK2. All samples were treated with ASN at the 1 h time 
point, leading to abrogation of cpxP-GFP expression. This effect was countered by 
inducing CsrB expression with addition of IPTG at either the 1 or 4 h time points.
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indirect support for this possibility, I found that the addition of 0.2% glucose to stationary 
phase cultures that were grown in the presence of 1 mM ASN resulted in the restoration 
of cpxP-GFP expression (Fig. 2.6.c). This effect may be explained by  the ability of 
glucose to indirectly activate the BarA-UvrY two-component system, resulting in 
elevated CsrB levels and subsequent inhibition of CsrA (68). However, this interpretation 
is clouded by the fact that glucose can stimulate CpxP expression via the 
phosphotransacetylase-acetate kinase pathway and the generation of acetyl phosphate, 
which can directly  activate CpxR (70-72). As a more direct test of CsrA involvement, I 
utilized an IPTG-inducible CsrB expression construct. Induced expression of CsrB either 
coordinate with the addition of ASN in early  growth phase, or later as UTI89 entered late 
log phase growth, rescued expression of the cpxP-GFP reporter (Fig. 2.6.d). Together, 
these data indicate that  CsrA can negatively affect  the translation of cpxP in the presence 
of nitrosative stress.
Overexpression of CpxP enhances bacterial growth in ASN
The physiological consequences of RNS effects on the Cpx pathway, and CpxP 
specifically, were addressed using isogenic mutants of UTI89 lacking cpxP, cpxR, or 
cpxA. In control experiments, I noted that the $cpxR and $cpxA mutants were 
hypersensitive to amikacin, while the $cpxP mutant displayed enhanced resistance to this 
antibiotic (Fig. 2.7). These mutant phenotypes were rescued by  complementation with 
plasmids encoding either cpxRA or cpxP, as appropriate. These results mirror those from 
previous studies in which K12 E. coli strains having mutated cpx genes displayed altered 
growth phenotypes in the presence of amikacin (73). Growth of UTI89 mutants lacking 
  45
4646
FIG 2.7. Trans complementation of the cpx mutants. Wild-type UTI89 and the cpx 
null mutants ($cpxA, $cpxR, and $cpxP), each carrying either the empty vector control 
pGEN-MCS or complementation plasmids, were grown overnight shaking in LB broth in 
the presence of ampicillin, as needed, to better maintain plasmid selection. Serial 
dilutions of the overnight cultures were spotted onto LB agar plates containing 3 µg·ml-1 
amikacin, and incubated for 24 h at 37°C. The image shows bacterial growth on the 
amikacin plates, with dilutions starting at 10-2 on the left  and ending at 10-6 on the right. 
Plasmid pJLJ41 encodes cpxP downstream of its native promoter, while pJLJ42 encodes 
the cpxRA operon under control of its native promoter. Due to polar effects, the 
expression of cpxA is likely disrupted in the $cpxR mutant, and so pJLJ42 was used for 
complementation of both the $cpxR and $cpxA mutant strains.
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any one of the cpx genes in LB or MES-LB broth ± 1 mM ASN was not notably  different 
from the wild-type control strain (data not shown), suggesting that the Cpx system is not 
essential for UPEC resistance to RNS. However, induced overexpression of CpxP did 
enhance UPEC growth in the presence of ASN, enabling this pathogen to reach mid-log 
(=0.5) about 1 h ahead of controls (Fig. 2.8). This lead was reduced to 30 min in the 
absence of ASN.
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Fig. 2.8. Overexpression of CpxP enhanced UPEC growth in the presence of RNS. 
Curves indicate the growth of UTI89 carrying either an empty vector control (EV, 
pRR48; dotted lines) or the IPTG-inducible CpxP expression construct  pRRK12 (OE; 
solid lines). All samples were grown in the presence of 1 mM  IPTG ± 1 mM ASN, as 
indicated. Lines depict mean values from quadruplicate samples ± S.D.
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Cpx confers a competitive advantage to
UPEC within the urinary tract
While deletion of the cpx genes had no detrimental effect on growth of UTI89 in 
my in vitro assays, I reasoned that phenotypes associated with these mutants may  become 
more apparent within the urinary tract where the pathogens are likely to encounter much 
more stringent environments replete with RNS plus numerous other antimicrobial factors. 
To address this possibility, I employed a well-established mouse UTI model system in 
which 1X107 CFU of bacteria were inoculated into adult female CBA/J mice via 
transurethral catheterization. After 3 d, bacterial numbers present in the bladders were 
determined by plating tissue homogenates. When wild-type UTI89 and each of the cpx 
mutants were inoculated by themselves into separate mice, no significant differences in 
the numbers of bacteria recovered 3 d were later observed (data not shown). However, 
when wild-type UTI89 was mixed 1:1 with each cpx mutant prior to inoculation, the 
wild-type strain was able to effectively outcompete each mutant (Fig. 2.9). These results 
demonstrate that the Cpx system can provide a clear competitive advantage to UPEC 
during the course of a UTI, supporting the possibility that dysregulation of the Cpx 
pathway by RNS may modulate bacterial fitness within the host environment. 
Discussion
While the Cpx stress response pathway is known to modulate a number of 
virulence- and stress-associated phenomena in UPEC in vitro (23, 74), this is the first 
study to show that Cpx components significantly  affect the fitness of UPEC within the 
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host during the course of a UTI. The diminished fitness of the cpxP null mutant is 
particularly intriguing considering its role as an auxiliary factor that is not strictly 
required for activation of the Cpx system (46, 47). Raivio and colleagues have suggested 
that the primary function of CpxP within the periplasm is to adjust the sensitivity  of the 
CpxA histidine kinase to appropriate levels as environmental conditions vary (75). 
Accordingly, it  was reported that deletion of cpxP leaves CpxA in a more active state, and 
consequently less responsive to Cpx-inducing cues (46, 48, 75). Therefore, modulation of 
CpxP levels within the periplasm likely provides UPEC and other bacteria with a means 
to fine-tune Cpx responses. The modulatory effects of CpxP may become more critical in 
rapidly changing and hostile environments as encountered within the host. 
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Fig. 2.9. Competitive advantage of wild-type UTI89 over isogenic cpx mutants 
within the bladder.  Adult female CBA/J mice were inoculated with a 1:1 mixture of 
wild-type UTI89 with each of the individual cpx null mutants, $cpxA, $cpxR, or $cpxP. 
After 3 d, wild-type and mutant titers present within the bladder were determined. Data 
are presented as (A) total CFU/g bladder tissue and as (B) competitive indices, with 
values >0 indicating that the wild-type strain outcompeted the mutant within the host. 
The horizontal bars indicate median values for each group. P values were determined 
using Mann-Whitney U tests (n = 12-13 mice).
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CpxP levels can be adjusted at the transcriptional level via activation of CpxR 
(46), or posttranslationally within the periplasm by  proteolysis mediated by DegP (48, 
49). Results presented here indicate a third mechanism involving translational repression 
of cpxP transcripts in the presence of RNS. Posttranscriptional control of mRNA 
transcripts in bacteria can be mediated by regulatory  sRNA molecules or by  RNA-
binding proteins like CsrA. The RNA chaperone Hfq often promotes interactions between 
sRNA molecules and specific transcripts, usually  resulting in accelerated decay or 
repressed translation of the target message (76). I recently reported that Hfq is a key 
regulator of multiple fitness and virulence phenotypes associated with UPEC, including 
resistance to high levels of RNS (77). However, Hfq was not required for RNS-mediated 
abrogation CpxP expression in UPEC as observed in this study (data not shown). Rather, 
my data implicate CsrA, a global regulatory protein that binds as a dimer to the 5’-UTRs 
of target transcripts, often occluding the Shine-Delegarno sequence (66, 78-84). 
CsrA recognizes the consensus sequence RUACARCGAUGU in target  transcripts 
(85), and can act  to either promote or repress translation. Key systems that are negatively 
controlled by CsrA include glycogen synthesis, gluconeogenesis, and biofilm 
development (84, 86-89). CsrA positively  affects glycolysis, acetate metabolism, and 
motility, with the latter being mediated via translational effects on the master regulator of 
motility, FlhDC (64, 87, 90). The ability  of CsrA to enhance translation of the flhDC 
mRNA likely  contributed to the high abundance of motility-associated genes that I 
detected by  microarray analysis as being highly upregulated in UTI89 grown in the 
presence of ASN. Stimulation of these motility  genes by  ASN may represent a defense 
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UTI89 UPEC cystitis isolate (104, 105)
MM530 UTI89 !cpxA::clm This study
MM639 UTI89 !cpxP::clm This study
MM427 UTI89 !cpxR::clm This study
TT23216 Salmonella template strain containing a clmR cassette 
flanked by universal primer sequences
J. Roth, (77)
MM173 UTI89/pJLJ5 This study
MM495 UTI89/pJLJ10 This study
MM1097 UTI89/pRR48 This study
MM1095 UTI89/pRRK12 This study
MM371 UTI89/pGFP(ASV) This study
MM638 UTI89/pKM208 This study
MM527 UTI89/pJLJ5/pHJ13 This study
MM503 UTI89/pJLJ5/pLD404 This study
MM531 UTI89 !cpxA::clm/pJLJ5 This study
MM444 UTI89 !cpxR::clm/pJLJ5 This study
MM315 UTI89/pMMB66EH This study
MM316 UTI89/pMMB66EH/pJLJ5 This study
MM511 UTI89/pJLJ5/pMMB66EH This study
MM512 UTI89/pJLJ5 /pRelA This study
MM641 UTI89 cpxA::clmR/pJLJ5 /pMM66EH This study
MM533 UTI89 cpxA::clmR/pJLJ5/pMMBRelA This study
MC4100 Laboratory K12 E. coli strain Coli Genetic 
Stock Center
Plasmids




pGFP(ASV) Expresses GFP(ASV) from Plac promoter; Ampr Clontech
pJLJ1 Control vector carrying promoterless gfp(ASV); Kanr This study
pJLJ5 Vector for expression of GFP(ASV) from the cpxP 
promoter region; Kanr
This study







pRR48 lacIq/ptac expression vector; Ampr S. Parkinson, 
(103)
pRRK12 IPTG-inducible CpxP expression construct; Ampr This study
pRRK1 Parental plasmid for pRRK2, derived from pRR48 by 
mutation of the Shine-Dalgarno sequence; Ampr
This study
pRRK2 Encodes IPTG-inducible CsrB; Ampr This study
pLD404 Vector for constitutive expression of NlpE; Ampr (53)
pHJ13 Encodes IPTG-inducible PapE; Ampr (45)
pKM208 IPTG-inducible Red recombinase expression plasmid; 
Ampr
(107)
pJLJ41 Expresses CpxP under its native promoter; Ampr This study
pJLJ42 Expresses CpxRA under its native promoter; Ampr This study
pGEN-MCS Parent plasmid for pJLJ41 and pJLJ42, contains hok 
sok post-segregation killing system and two par loci; 
Ampr
-102
pMMB66EH Empty-vector control vector for pRelA; Ampr (113)







MP141 – F AACTGGATCCTCATTGTTTAAATACCTCCG pJLJ5
MP142 – R TGATGGTACCTTGCTCCCAAAATCTTTCGT pJLJ5
MP149 – F CGCTCGGATCCCATCATTTGCTCCCAAAATCTT pJLJ10













P222 - F GTGAGCGGATAACAATTTACTGCAGTGTGAAATGCTGC
AGGATCCG
pRRK1
P223 - R CGGATCCTGCAGCATTTCACACTGCAGTAAATTGTTATC
CGCTCAC
pRRK1
P216 - F GGGGTACCCCAACTGCCGCGAAGAATAGCA pRRK2
P224 - R CAATGCATTGGTTCTGCAGTTTTGTCTGTAAGCGCCTTG
TAA
pRRK2
P322 - F CGGGATCCCAGATTTTGGGAGCAAATGATGCG pRRK12
P323 - R GGGGTACCAAGCAGCAGGCAAATTGAGGATAAA pRRK12
RT-PCR
MP22 - F TCATTAAGCCACGCTGCTGA cpxP
MP23 - R ACTCAATAGCTTCAACGATGAA cpxP
MP24 - F ATGACCAGCCACACTGGAACT 16S rRNA
MP25 - R AGTATCAGATGCAGTTCCCAG 16S rRNA
MP43 - F AGGGTGAAGGTGATGCAACA gfp
MP44 - R CTCAAGAAGGACCATGTGGT gfp
MP45 - F AAAGTCATGGATTAGCGACGT cpxR
MP46 - R TCAGCACTAAGGCATCAACTT cpxR
TABLE 2.2. Primers used in this study
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strategy for UPEC, enabling these pathogens to better evade RNS generated within the 
host or other environments. 
The microarray results suggested CsrA activity may be of significant consequence 
to UPEC in the face of RNS. To test this possibility, I tested the ability  of CsrA to 
modulate CpxP levels. Although I was able to construct a csrA null mutation for this 
purpose, this mutant strain proved to be exceptionally  difficult to work with, forming 
large insoluble aggregates that have made subsequent analyses problematic. 
Consequently, I resorted to alternate approaches. CsrA is antagonized by  the sRNA CsrB, 
the transcription of which is promoted by activation of the BarA-UvrY two-component 
system, which responds to glucose and, more specifically, the glucose metabolic end 






MP47 - F ATGCGGCGTAAACGCCTTATCCTGCCTACAAATGCGGAG
TCACCAAACACCCCCCAAAACC
cpxA
MP48 - R AAACCTTGCGTGGTCGCGGCTATCTGATGGTTTCTGCTT
CCACACAACCACACCACACCAC
cpxA
MP63 - F CTCTCTATCGTTGAATCGCGACAGAAAGATTTTGGGAGC
AACACCAAACACCCCCCAAAACC
cpxP
MP64 - R GAAGACAGGGATGGTGTCTATGGCAAGGAAAACAGGG
TTTCACACAACCACACCACACCAC
cpxP
MP143 - F ATGAATAAAATCCTGTTAGTTGATGATGACCGAGAGCTG
ACTTCCCTATTTGTGTAGGCTGGAGCTGCTTCG
cpxR




a F and R refer to forward and reverse primers.
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regulated by CsrA, creating an autoregulatory  loop (67). In my assays, ASN-mediated 
attenuation of CpxP translation was countered by the induced expression of CsrB, as well 
as addition of the BarA activator glucose. 
These observations link the regulation of the Cpx system to a number of pathways 
that are integral to bacterial fitness in general, and to UPEC virulence in particular. 
Specifically, the BarA-UvrY system has been implicated as a virulence determinant for 
UPEC within the urinary tract (91), and the capacity of CsrA to control biofilm formation 
and carbon utilization pathways has implicit relevance to the survival of UPEC within the 
host (92-94). Recently, it  was reported that UPEC isolates are often much better equipped 
to handle RNS, being able to survive and adapt to high levels of ASN (2, 57, 95). Part of 
this adaptive response involved upregulation of the polyamine cadaverine, which can 
facilitate UPEC growth in the face of RNS (2, 57). Interestingly, FlhDC acts as a positive 
regulator of cadA, which encodes a lysine decarboxylase involved in cadaverine 
biogenesis (96), suggesting another link between CsrA and the fitness and virulence 
potential of UPEC. 
The ability of CsrA to repress CpxP expression in the presence of ASN is also 
likely pertinent to the pathogenesis of UTIs. On one hand, CsrA-mediated effects on cpxP 
translation may act as part of an adaptive response, altering activation levels of CpxA and 
perhaps enabling UPEC to better deal with the effects of nitrosative stress on the bacterial 
envelope. Alternatively, dysregulation of the Cpx system due to RNS may represent  a 
specific detriment with which UPEC must  deal. RNS-mediated downregulation of CpxP 
expression in conjunction with additional stresses and antimicrobial factors encountered 
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within the host  may act to restrict UPEC growth and dissemination. This scenario is 
supported by my observations that a cpxP null mutant is significantly disadvantaged 
within the host urinary tract, at least when in competition with the wild-type pathogen.  In 
the end, it is likely that RNS-mediated attenuation of CpxP expression will have variable 
effects on UPEC fitness depending on the cumulative input of multiple signaling systems 
and environmental cues.  
Whether or not CsrA abrogates CpxP expression by  directly  interacting with cpxP 
transcripts or by other less direct means remains to be tested. Using a primer walking 
technique, I determined that the 5’-UTR of cpxP extends at least 45 bp upstream of the 
translation start  site (see Fig. 2.1.a and data not shown). Within this region there is 
potentially one degenerate CsrA binding site overlapping the Shine-Delgarno sequence. It 
is feasible that modification of CsrA in the presence of RNS alters its binding specificity, 
enabling CsrA to recognize an alternate repertoire of mRNA transcripts. In support of this 
possibility, I have found by both Western blot analysis and mass spectroscopy that a 
highly  conserved tyrosine residue (Y47) within CsrA becomes nitrated when purified 
CsrA is exposed to ASN (unpublished observations). Y47 is located within a loop region 
surrounded by residues known to mediate CsrA-RNA interactions (81, 97). I am currently 
working to understand the functional significance of Y47 nitration. However, it is 
noteworthy  that there is a growing body of evidence that  tyrosine nitration in eukaryotic 
systems can modify protein function and alter signaling cascades (98-101). Since UPEC 
can produce their own RNS via nitrite reductases under conditions of low oxygen tension, 
as often encountered within host niches like the bladder (7), it  may be that these bacteria 
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Plasmids and primers used in this study are listed in Tables 2.1 and 2.2, 
respectively. To create the cpxP-gfp promoter fusion, the 146 bp region between the 
divergent start sites of cpxR and cpxP from the E. coli strain MC4100 was amplified by 
PCR using primers MP141 and MP142 (Table 2.2). The PCR product  was digested with 
BamH1 and Asp718 and ligated into the multiple cloning site of pGFP(ASV) 
(Clonetech). The resulting plasmid was digested with BamH1 and BsiW1 to generate a 
~900 bp fragment containing the cpxP promoter upstream of the gfp(ASV) gene. This 
fragment was ligated into the BamH1 and Ban1 sites of the low copy number plasmid 
pACYC177 (New England Biolabs) to create pJLJ5. To construct pJLJ10, the 146 bp 
cpxP promoter region in pJLJ5 was replaced with the same sequence in the opposite 
orientation. As a control, plasmid pJLJ1 was constructed by ligating the promoterless gfp
(ASV) gene from pGFP(ASV) into the BamH1 and Ban1 sites of pACYC177. In control 
experiments, E. coli strains carrying pJLJ1 did not express any detectable GFP under any 
conditions tested. Plasmid pJLJ41 was made by first amplifying cpxP off the UTI89 
chromosome along with 250 bp  of upstream and 100 bp of downstream sequences using 
primers CpxPfor(pst1) and CpxPrev(salI). The resulting PCR product was digested and 
ligated into PstI and SalI sites within the high-retention, low copy number plasmid 
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pGEN-MCS (102). pJLJ42, carrying cpxRA plus 250 bp of upstream and 100 bp of 
downstream sequences, was similarly constructed using primers CpxRAfor(pst1) and 
CpxRArev(salI). 
Plasmids pHJ13 (encoding IPTG-inducible PapE), pLD404 (for constitutive 
expression of NlpE), pMMBrelA (for IPTG-inducible expression of RelA), and the 
expression construct pRR48 have been described previously (45, 53, 56, 103). To create 
pRRK12, the cpxP sequence from UTI89 was amplified using primers P322 and P323, 
which introduced flanking 5'-BamH1 and 3'-Kpn1 restriction sites used to ligate cpxP 
downstream of the tac promoter in pRR48. Plasmid pRRK1 was constructed using 
primers P222 and P223 to mutate the Shine-Dalgarno sequence within pRR48 to a PstI 
site (Site-Directed Mutagenesis II Kit, Stratagene). The csrB coding sequence from 
UTI89 was amplified using primers P216 and P224 and ligated into PstI and BamHI sites 
within pRRK1 to create pRRK2.
Bacterial strains and growth conditions
Strains used in this study  are listed in Table 2.1. Plasmids were introduced into 
UTI89, a human cystitis isolate (104, 105), by electroporation. Targeted gene knockouts 
were created in UTI89 using linear transformation and lambda Red-dependent 
recombination essentially  as described (106, 107). Primers were designed to amplify  the 
chloramphenicol (clm) resistance gene from strain TT23216 with appropriate flanking 
sequences having homology to regions within and around cpxR, cpxA, or cpxP. All gene 
knockouts were verified by PCR of the affected genomic regions. 
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TABLE 2.3. Top one hundred upregulated microarray genes
Gene
UTI89 Locus 
Tag Function Ratioa Probe setb
ygbD C3073 Flavorubredoxin oxidoreductase 2,554.8 1766754_s_at
flgB C1198 Flagellar biosynthesis 1,612.4 1762105_s_at
norV C3072 Flavorubredoxin 1,253.1 1768449_s_at
723.4 1767683_at
53.9 1768764_s_at
flgE C1201 Flagellar biosynthesis 1,246.4 1760787_s_at
flgC C119 Flagellar biosynthesis 1,227.1 1768120_s_at
flgD C1200 Flagellar biosynthesis 1,158.2 1760643_s_at
flgG C1203 Flagellar biosynthesis 1,155.5 1767435_s_at
fliM C2145 Flagellar biosynthesis 617.0 1761189_s_at
fliL C2144 Flagellar biosynthesis 551.8 1768910_s_at
ycdO C1081 Hypothetical protein 548.7 1764800_s_at
206.6 1763371_at
fliN C2146 Flagellar biosynthesis 406.9 1765241_s_at
flgA C1197 Flagellar biosynthesis 358.0 1763116_s_at
fliA C2123 Flagellar biosynthesis 317.6 1763490_s_at
flgH C1204 Flagellar biosynthesis 286.3 1768045_s_at
fliK C2143 Flagellar biosynthesis 205.5 1759897_s_at
flgJ C1206 Flagellar biosynthesis 202.0 1763207_s_at
flgF C1202 Flagellar biosynthesis 182.8 1761549_s_at
fliF C2138 Flagellar biosynthesis 175.3 1763750_s_at
fliO C2147 Flagellar biosynthesis 164.8 1761160_s_at
flgK C1207 Flagellar biosynthesis 153.0 1761245_s_at
fliI C2141 Flagellar biosynthesis 152.1 1766980_s_at
yoga C1994 Hypothetical protein 146.7 1762744_s_at
ycdB C1082 Hypothetical protein 137.8 1768768_at
fliJ C2142 Flagellar biosynthesis 136.9 1760976_s_at
flgI C1205 Flagellar biosynthesis 112.7 1765040_s_at
cysI C3127 Sulfite reduction 112.5 1768272_s_at
76.8 1767086_at
fliC C2124 Flagellar biosynthesis 99.1 1765832_s_at
c2201 C1993 Hypothetical protein 92.8 1762869_s_at
fliG C2139 Flagellar biosynthesis 81.8 1766530_s_at
Flip C2148 Flagellar biosynthesis 79.7 1767430_s_at
fliD C2125 Flagellar biosynthesis 79.5 1764241_s_at
tar C2089 Chemotaxis 74.7 1768914_s_at





Tag Function Ratioa Probe setb
Aer C3510 Chemotaxis 69.9 1766701_s_at
flhA C2082 Flagellar biosynthesis 69.7 1767873_s_at
Tap C2088 Chemotaxis 67.4 1766991_s_at
c3225 C3031 Hypothetical protein 62.4 1768634_s_at
flhB C2083 Flagellar biosynthesis 59.4 1766226_s_at
cysJ C3128 Sulfite reduction 55.9 1765526_s_at
fliZ C2122 Flagellar biosynthesis 51.2 1760453_s_at
cheA C2091 Chemotaxis 47.9 1766750_s_at
aceA C4574 Isocitrate lyase 46.6 1763981_s_at
ybdB C0599 Hypothetical protein 43.8 1761866_s_at
cysH C3126 Sulfite reduction 43.3 1760382_at
25.5 1759826_s_at
fdnI C1692 Formate dehydrogenase 42.1 1760891_s_at
fliS C2126 Flagellar biosynthesis 40.9 1764033_s_at
flgL C1208 Flagellar biosynthesis 40.8 1768710_s_at
cysP C2758 Sulfite reduction 39.5 1764785_at
11.0 1762292_s_at
Nark C1420 nitrite extrusion protein 37.7 1764323_s_at
fliH C2140 Flagellar biosynthesis 36.8 1760053_s_at
motA C2093 Chemotaxis 35.6 1763982_s_at
fdnH C1691 Formate dehydrogenase 34.3 1763995_s_at
cheR C2088 Chemotaxis 33.5 1760164_s_at
cheW C2090 Chemotaxis 30.6 1759302_s_at
cheY C2086 Chemotaxis 29.4 1764851_s_at
c2419 C2178 Hypothetical protein 28.5 1763274_at
cysA C2755 Sulfate transport 28.4 1762301_at
cheB C2087 Chemotaxis 26.6 1765173_s_at
fliQ C2149 Flagellar biosynthesis 26.6 1766705_s_at
iscR/yfhP C2853 Fe-S cluster-containing transcription factor 25.9 1764175_s_at
cysD C3123 Sulfate adenylyltransferase 22.5 1765655_s_at
cheZ C2085 Chemotaxis 22.1 1765504_s_at
yghK C3391 Glycolate permease 21.8 1759891_s_at
Flit C2127 Flagellar biosynthesis 19.7 1762151_s_at









Tag Function Ratioa Probe setb
yhjC C4053 Transcriptional regulator 18.0 1767782_s_at
betB C0341 Betaine aldehyde dehydrogenase 17.6 1766956_at
fdnG C1689 Formate dehydrogenase 16.7 1761354_s_at
marB C1751 Multiple antibiotic resistance protein 16.7 1760768_s_at
chuS C4027 Heme/hemoglobin transport protein 15.7 1763313_s_at
cysN C3122 ATP-sulfurylase 14.9 1763768_s_at
yhjH C4057 Chemotaxis 14.8 1765046_s_at
beta C0340 Choline dehydrogenase 13.2 1766741_at
gltB C3649 Glutamate synthase 13.2 1768316_at
sitA C1339 Fe Transport 13.1 1761573_at
chuX C4035 Hypothetical protein 12.7 1769108_s_at
flhE C2081 Flagellar biosynthesis 11.6 1767174_at
aceB C4573 Malate synthase A 11.3 1761179_at
flgM C1196 Flagellar biosynthesis 11.1 1768555_s_at
cysU C2757 Sulfate transport system permease 10.9 1759413_at
cysC C3121 Adenylylsulfate kinase 10.8 1761476_s_at
ymdA C1167 Hypothetical protein 10.6 1764274_s_at
iscS/yfhO C2582 Cysteine desulfurase 10.5 1759704_s_at
fhuF C5073 Ferric iron reductase protein fhuF 10.5 1761858_at
dnaJ C0017 Chaperone 10.5 1769019_s_at
yjcZ C4704 Hypothetical protein 10.4 1763969_s_at
motB C2092 Chemotaxis 10.4 1767171_s_at
ycjX C1592 Hypothetical protein 10.3 1768270_s_at
yiaK C4117 Oxidoreductase 10.1 1759230_s_at
nrdH C3033 Glutaredoxin-like protein 9.9 1764080_s_at
cstA C0600 Carbon starvation protein A 9.6 1766639_s_at
acs C4659 Acetyl-CoA synthetase 9.2 1761238_s_at
cyoC C0454 Cytochrome subunit 9.0 1767399_s_at
tsr C5058 Chemotaxis 9.0 1762388_s_at
yeaJ C1982 Hypothetical 9.0 1767540_s_at
cyoE C0451 Cytochrome subunit 8.8 1759601_s_at
c2436 C2188 Putative pesticin receptor 8.8 1767260_at
ompT C0566 DLP12 Prophage 8.8 1765378_s_at
a Ratio of the expression in cultures containing ASN to the expression in cultures not containing ASN.
b When different probe sets for a single gene yielded different results, all probe sets are listed.
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Except where noted, UTI89 and its derivatives were cultured from -80°C frozen 
stocks in Luria-Bertani broth buffered at pH 5.0 with 100 mM  morpholineethanesulfonic 
acid (MES-LB). Kanamycin (50 %g·ml-1), ampicillin (50 %g·ml-1), and/or 
chloramphenicol (20 %g·ml-1) were included when appropriate to maintain plasmid 
selection. After an overnight incubation shaking at 37°C, bacteria were subcultured 1:100 
into fresh MES-LB.  Sodium nitrite and isopropyl &-D-1-thiogalactopyranoside (IPTG) 
were each added to a final concentration of 1 mM as indicated. Bacteria used for RT-
PCR, microarray, and Western blot analyses were grown shaking at 225 rpm at 37°C in 5 
ml cultures within 120x17 mm screw-capped polystyrene conical tubes (Sarstedt). 
Growth was monitored by determining the optical density at 600 nm using a Spectronic 
20D+ (Thermo). Other growth curves were obtained using shaking 200-ml cultures in 
100-well honeycomb plates and a Bioscreen C instrument (Growth Curves USA). 
Antibiotics, sodium nitrite, and MES were purchased from Sigma-Aldrich, while IPTG 
was from Teknova.
To test the sensitivities of the cpx mutants and complemented strains to amikacin, 
serial dilutions of overnight bacterial cultures (grown in LB broth in the presence of 
ampicillin to maintain plasmid selection) were plated as 5 ml drops on LB agar 
containing 3 %g·ml-1 amikacin.  After a 24 h-incubation at 37°C, plates were 




Bacterial samples were pelleted at 12000·g for 2-3 min at 4ºC, lysed in Bacterial 
Protein Extraction Reagent (Pierce), sonicated for 1 min, heated at  100ºC for 5 min, and 
stored overnight at  -20ºC. Equivalent amounts of protein (20 %g as determined by BCA 
assay, Pierce) from each sample were resolved in 10% acrylamide using sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and subsequently  transferred to 
PVDF membranes (Millipore) for Western blot  analysis. All antibody  incubations were 
performed in 1% BSA, 1% powdered milk, 0.1% Tween-20 in Tris-Buffered Saline (pH 
7.4). Blots were incubated with mouse anti-GFP (1:10,000; Santa Cruz) for 45 min at 
room temperature, followed by a 1-h incubation with secondary  anti-mouse HRP-
conjugated IgG antibody (1:10,000; Amersham Biosciences). Blots were then washed, 
developed using the SuperSignal West Pico or SuperSignal West Femto 
Chemiluminescent kit  (Pierce), and exposed to CL-XPosure Film (Pierce). To ensure that 
equivalent amounts of protein from each sample were loaded, duplicate gels were stained 
using GelCode Blue (Pierce) and/or blots were re-probed using goat anti-E. coli antisera 
(1:1,000; BioDesign).
Microarray sample preparation
Four separate colonies of UTI89 grown on LB agar plates from a freezer stock 
were used to start overnight shaking cultures in LB-MES broth. These were then diluted 
1:100 into 5 mL LB-MES and grown shaking ± ASN at 37ºC in duplicate 120x17 mm 
screw-capped conical tubes until the OD600 was 0.8, at which point the bacteria were 
quickly pelleted and frozen at -80°C for at least 12 h. RNA was extracted using hot 
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phenol-chloroform and purified by CsCl gradient centrifugation (108). Synthesis of 
cDNA and subsequent fragmentation and labeling were performed according to 
Affymetrix protocols.
Microarray gene expression analysis
Fragmented and labeled cDNA (15 %g) was mixed with 270 %l hybridization 
buffer and hybridized to Affymetrix GeneChip E. coli 2.0 genome arrays at 45ºC for 20 h. 
The GeneChips were then washed, stained, and scanned using Affymetrix protocols and 
an Affymetrix GeneChip 3000 device with high-resolution scanning enabled. Raw 
images were converted to CEL files with Affymetrix GCOS software and image 
processing using the GCRMA method for probe-level data (109) was carried out using 
the Bioconductor Package in the R statistical environment (110). CEL files were analyzed 
as a group, background corrected using GCRMA (111), and normalized using quantile 
normalization. Median polish was used to obtain probe set summary measures. 
Organization of transcripts was based on available gene data from Affymetrix NetAffx 
(http://www.affymetrix.com/analysis/index.affx), the annotated UTI89 genome (105), and 
EcoCyc (http://ecocyc.org/, (112)).
Microarray data accession number





Total RNA was collected from bacterial cultures (grown ± ASN to an  of 0.8) as 
described above. M-MLV reverse transcriptase (Ambion, Austin, TX) was used to reverse 
transcribe 1 %g of total RNA using random hexamer primers (Invitrogen) followed by 
PCR with gene-specific primers listed in Table 2.2 under the RT-PCR heading. Reactions 
set up without reverse transcriptase were used as controls. Amplicons ranging in size 
from 340 to 570 bp  were resolved using 2% agarose gels, stained with ethidium bromide, 
and imaged using a GelDoc system (Bio-Rad Laboratories). Integrated band intensities 
were quantified using ImageJ software (NIH).
Mouse infections
Seven to 8 week old female CBA/J mice (Jackson Labs) were used in accordance 
with IACUC-approved protocols. Wild type UTI89 and the cpx knockout strains were 
grown from frozen stocks in 20 ml static LB broth at 37ºC for 24 h. Bacteria were 
pelleted by centrifugation for 8 min at 8,000·g and then resuspended in phosphate-
buffered saline. Mice were briefly anesthetized using isofluorane inhalation and 
inoculated via transurethral catheterization with 50 ml of a bacterial suspension 
containing ~1 X 107 CFU total bacteria. For competition assays, wild type UTI89 and 
each cpx mutant strain were mixed 1:1 prior to inoculation. After 3 d, bladders were 
collected, weighed, and homogenized in PBS containing 0.02% Triton X-100. 
Homogenates were serially  diluted and plated on LB agar plates ± chloramphenicol to 
determine the number of bacteria present per gram of tissue and to distinguish wild type 
UTI89 from the cpx knockout mutants. Competitive indices were calculated as Log10
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[(wild-type CFU recovered/mutant  CFU recovered)/(wild-type CFU inoculated/mutant 
CFU inoculated)], such that values of greater than 0 indicate that the wild type strain 
outcompeted the mutant. Mouse experiments were repeated twice with similar results 
(total combined data is presented in Fig. 2.9).
Statistics
Results from the mouse experiments were analyzed by Mann-Whitney U tests 
using Prism 5.01 software (Graphpad Software). P values of less than 0.05 were 
considered significant. 
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CHAPTER 3
IMPACT OF THE RNA CHAPERONE HFQ ON THE FITNESS
AND VIRULENCE POTENTIAL OF  UROPATHOGENIC
ESCHERICHIA COLI
Reprinted with Permission from the American Society for
Microbiology, Infection and Immunity, 2008,










SUPPLEMENTAL TABLE 3.1. Primers used in this study.



























a Underlined sequences allow amplification of antibiotic resistance cassettes flanked by universal 
primer sites in strains TT23216 and TT23691.
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SFig 3.1. Disruption of hfq alters the LPS profile of UPEC. Image shows silver-stained 




UPEC are adaptive pathogens
UPEC are versatile pathogens capable of colonizing multiple environments within 
the host, including the alimentary  canal, perineum, urethra, bladder, ureters and kidneys. 
UPEC can also persist intracellularly within phagocytes or within bladder epithelial cells, 
where they may set  up long-term residence (1). As the local environment changes, UPEC 
must rapidly adapt to survive. Stress conditions, such as changes in pH, osmolarity  (2, 3), 
mechanical forces (4), disruptive host proteins, and chemical stresses such as reactive 
nitrogen species (RNS) (5-7) and reactive oxygen species (ROS) (8,9), are all known to 
induce corresponding changes in bacterial behavior as the microbes attempt to cope with 
these insults. These stresses may impact protein folding in the periplasm where repeating 
subunits of surface organelles, such as pili fibers, curli, and flagella, are assembled in 
tightly regulated processes involving numerous chaperones and other co-factors (10-13). 
Intimate control of envelope constituents is required, therefore, to prevent misfolding and 
aggregation of transported subunits. A portion of this critical control falls into the realm 
of posttranscriptional regulation (PTR), with small noncoding RNAs (sRNA) mediating 
both the decay of outer membrane protein (OMP) transcripts (14-21) and regulation of 
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the critical  !E envelope stress response pathway (17, 22, 23). In addition, UPEC employ 
motility to ascend the urinary tract, and generate both extra- and intracellular biofilms as 
part of their pathogenic lifestyle (24, 25). Both motility and biofilm production are 
regulated centrally by PTR, namely through the protein-RNA mediator CsrA (26-29).
In employing the naturally high resistance of UPEC to nitrosative stress to test for 
activation of the Cpx envelope stress response pathway, I uncovered a posttranscriptional 
mechanism for downregulation of CpxP. CpxP is an accessory adaptor protein component 
of the Cpx system that works to ameliorate envelope stress. Seeking to determine the 
mechanism of this downregulation phenomenon, I examined the involvement  of both 
major arms of PTR in UPEC. First, the protein-mediated arm of PTR was investigated for 
its role in the downregulation of CpxP by modulating CsrA activity by way of an 
endogenous inhibitory pathway and by using an sRNA antagonist to CsrA, namely, CsrB. 
Second, PTR mediated by sRNAs was globally  approached by deletion of the RNA 
chaperone Hfq, a factor required by  the majority  of sRNAs to mediate interaction with 
target mRNAs (30-33). Although the nature and severity of the defects varied between 
these two PTR categories, regulation of key envelope processes was common to both.
The Protein-mRNA mediated arm of PTR: CsrA
In this work I demonstrate that CsrA contributes to stress resistance by 
modulating an envelope stress response pathway, the Cpx two-component system. As 
discussed in Chapter 2, nitrosative stress conditions, rather than increasing cellular levels 
of CpxP, resulted in its ablation. This downregulation could be overcome by adding 
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exogenous glucose. Adding exogenous glucose is a pleiotropic treatment, as carbohydrate 
transporters and metabolic pathways are highly  upregulated and activated to deal with 
this preferred nutrient source. However, glucose metabolism produces the byproducts 
formate and acetate, which in turn activate the BarA/UvrY two-component system (34). 
The BarA/UvrY system then upregulates expression of the sRNAs CsrB and CsrC, which 
directly  antagonize CsrA activity. To implicate CsrA directly in the downregulation of 
CpxP in RNS, I induced CsrB from an IPTG-inducible construct and demonstrated that 
CpxP expression could be restored despite prior treatment with RNS (see Figure 4.1.). 
Thus, antagonization of CsrA activity, either by glucose addition or ectopic expression of 
CsrB could prevent downregulation of CpxP in nitrosative conditions. These data imply 
action by CsrA in the nitrosative downregulation of CpxP.
How does CsrA regulate CpxP?
In light of the inferred regulation of CpxP by CsrA, the next question becomes: 
“How does CsrA regulate CpxP?” At the time of this writing there are no reports in the 
literature regarding regulation of the Cpx system by  CsrA. The posttranscriptional 
regulation of CpxP by CsrA, specifically under nitrosative conditions, thus suggests a 
novel mechanism. Although there is a degenerate CsrA-binding site within the cpxP 5' 
UTR composed of the bases cgACAgaaAgaU (capitalization indicates bases matching 
consensus), this region lacks multiple conserved bases critical for CsrA interaction 
according to the SELEX-derived CsrA-binding consensus ruACArGGAuGU (35). This 
suggests that  if CsrA is regulating cpxP translation directly, it does so under binding 
parameters different from other RNA substrates. Alternatively, but not exclusively, CsrA 
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may act indirectly  on cpxP translation via one or more secondary factors, which in turn 
regulate translation of the cpxP transcript.
Nitrosative stress may result in nitration of proteins at cysteine and tyrosine 
residues (36, 37). Since CsrA lacks cysteine residues, I investigated the possibility of 
tyrosine nitration via an anti-nitrotyrosine antibody on RNS-treated CsrA. CsrA in UPEC 
contains two tyrosine residues, Tyr48 and Tyr63. Immunoblotting indicated the nitration 
of CsrA during in vitro nitrosation assays (see Chapter 2).Tyr63 is present at the C-
terminus of CsrA in an unstructured region with little homology to CsrA from other 
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FIG. 4.1. Schematic representation of CsrA regulon. The posttranscriptional regulation 
of the Cpx system by CsrA under nitrosative stress conditions.
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species (38). In silico modeling of Tyr48 nitration reveals possible steric hindrance 
imposed on the C-terminal alpha-helix (see Fig. 4.2.). Though Tyr48 itself does not 
appear to be directly involved in the RNA binding interface, and in fact is present on the 
opposite face of the alpha-helix involved in RNA interaction, the adjacent Ile47 residue is 
functionally essential (38). Nitration of Tyr48 may result in translocation of the alpha-
helix where Ile47 resides, altering or abrogating RNA-binding.
Functional consequences of CsrA nitration
This nitration event could foreseeably  result in several non-exclusive possibilities. 
Nitration of CsrA may alter its stability  or dimerization kinetics. Nitration may also affect 
the binding repertoire, either altering CsrA's binding partner interactions or abolishing 
them altogether.
Once nitrated, is nCsrA's stability affected? Recently, ArgR, an E. coli negative 
regulator of arginine biosynthesis, was shown to degrade after in vitro tyrosine nitration 
(39). This raises the possibility that nitration of CsrA's Tyr48 or Tyr63 residues may 
result in CsrA degradation. However, my CpxP reporter assays seem to argue against 
rapid CsrA degradation. I observed abolishment of CpxP-GFP-ASV expression for at 
least 8 hours subsequent to application of nitrosative stress (Chapter 2, Figure 2.2.). As 
mentioned in Chapter 2, this abolishment of the reporter could be seen for as long as 24 h 
posttreatment. Thus the downregulation of the reporter by CsrA is sustained over many 
hours. If nCsrA were degraded rapidly, this would require constant resupply  of CsrA to 
maintain CpxP downregulation, even if CsrA functions indirectly. However, the 
microarray  analysis from the ASN-treated UPEC isolates evidenced csrA transcript levels 
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less than 50% of the untreated UPEC (0.412-fold change). Therefore, it is unlikely that 
nCsrA is rapidly  degraded in UPEC, although slow degradation exceeding 24 h)may 
occur.
Alternatively, CsrA nitration may be transient. Under this scenario, nCsrA may 
degrade faster than CsrA but remain in check because of the transient nature of nitration. 
If CsrA nitration is reversible, can UPEC utilize nitration as a posttranslational switch 
like phosphorylation? What cellular pathways contribute to denitration?
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FIG. 4.2. Modeling tyrosine nitration of CsrA. MacPymol (36) was used to model 
Escherichia coli CsrA, PDB entry 1Y00 (37). Tyrosine residues are shown in black. 
Functionally required residues are shown in blue while cyan indicates RNA-binding 
residues. A) Cartoon model of CsrA dimer. B) Space-filling model of A. C) Tyr48 shown 
in center amidst required residues. D) Nitrated Tyr48.
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Perhaps CsrA nitration alters or abrogates its regular binding repertoire. The 
biological possibility  of nitration altering protein function is well established. Tyrosine 
nitration acts as a gain-of-function modification in several eukaryotic systems (36, 37, 40, 
41). Numerous examples of protein nitration modulating protein function have also been 
described in mitochondria, as reviewed by Koeck et al. (42). The possibility  of nCsrA 
exhibiting modified function certainly exists.
Modified functions for nCsrA may include deactivation or alteration of binding 
partners or kinetics. For instance, nCsrA may recognize a different subset of mRNA 
transcripts. The latter option seems more feasible considering expression of CsrB was 
sufficient to alleviate repression of CpxP in the presence of nitrosative stress. Therefore, 
even if nCsrA has altered binding characteristics, CsrB is nevertheless capable of titrating 
CsrA away. Future RNA immunoprecipitation and cross-linking studies will likely 
address if nCsrA binds an alternate repertoire of RNA or protein targets. Most 
importantly, these studies will clarify if nCsrA can bind the cpxP leader region and 
influence its translation. It will be interesting to see what new targets, if any, nCsrA may 
be interacting with.
Considering CsrB's activity repressing CsrA despite nitrosative treatment, the 
nature of its RNA-binding becomes more intriguing. CsrB is known to bind CsrA with a 
stoichiometry  of 1:18 through many CsrA-binding sites of variable nucleotide 
composition (43). The known variability of these sites within CsrB, as well as its 
apparent ability to antagonize nCsrA, suggests that modification of CsrA binding 
specificity under different environmental conditions may be accounted for and held in 
95
96
check by  the variable binding loops of CsrB (and CsrC). The diversity of CsrB's binding 
sites for CsrA may indicate many altered binding conformations for CsrA, possibly under 
multiple conditions. If so, the variability  of CsrB's sites may  evidence an evolutionary 
adaptation to host-supplied antagonization of CsrA.
Activating the BarA/UvrY pathway, and CsrB, by adding glucose, and artificial 
CsrB overexpression both alleviate CpxP downregulation in ASN. This implicates CsrA 
activity in the process. A novel CsrA-binding site within the cpxP leader region may 
allow CsrA binding under noncanonical conditions. The possibility CsrA may be nitrated 
at a tyrosine residue adjacent to the alpha-helix may enable this noncanonical binding. 
Nitrated CsrA may  also exhibit altered stability and dimerization characteristics. Nitrated 
CsrA may bind other noncanonical targets, influencing their translation. This last 
possibility demands further investigation to determine binding kinetics, targets, and other 
possible downstream effects.
PTR by Hfq
I have shown that Hfq-mediated regulation in UPEC is extremely  advantageous. 
Loss of the RNA chaperone Hfq results in significant colonization defects in murine 
models of cystitis and pyelonephritis despite normal in vitro growth. Intracellular 
bacterial communities (IBCs) were virtually absent from an !hfq mutant despite normal 
adherence to, and invasion of, host cells. Although the !hfq mutant exhibited similar in 
vitro growth characteristics to the parental strain, the mutant had marked defects in 
biofilm formation, motility, and resistance to ROS, RNS, and cationic peptides. 
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Additionally, the hfq deletion mutant exhibited a notably abnormal lipopolysaccharide 
(LPS) profile. Prior literature suggests phenotypes observed in hfq deletion strains are 
attributible to effects on the !S or !E stress-induced alternative sigma factors (44-46). I 
demonstrated that phenotypes observed from the !hfq mutant are not exclusively 
attributable to loss of !S or !E function by including UPEC rpoS and rpoErseABC gene 
deletion mutants as controls. This suggests Hfq is performing additional roles in UPEC 
pathogenesis beyond those mediated by these stress-responsive alternative sigma factors, 
and implies the involvement of sRNAs in the overall pathogenesis of UPEC beyond those 
known to regulate !S or !E. My studies have globally implicated Hfq, and thus sRNAs, in 
UPEC pathogenesis. Further studies will delineate which sRNAs are responsible for 
which aberrant !hfq UPEC phenotypes.
More specifically, these data demonstrate the great control Hfq exerts on UPEC’s 
envelope. As mentioned above, the hfq mutant’s LPS profile contains LPS constituents of 
decreased molecular weight via polyacrylamide gel electrophoresis. Presumably, this 
results from defects in polysaccharide biosynthesis, transport, polymerization, or 
turnover. The hfq null UPEC was highly  sensitive to the cationic peptide polymixin B, 
demonstrative of envelope damage or compromised envelope maintenance or stress 
response pathways. Together, these data imply the necessity  of Hfq for proper envelope 
maintenance by demonstrating envelope alterations in its absence. This hypothesis is 
enhanced by the reduced motility  and defective in vivo IBC formation seen with the hfq 
null mutant, since assembly of the flagella and biofilms are both processes requiring 
numerous periplasmic chaperones and transport complexes through the envelope.
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LPS alteration: symptom or cause?
LPS is a significant envelope component, both in physical abundance, but also in 
imparting structure and survival of environmental conditions (as reviewed by (91)). 
Perturbations to UPEC LPS could have profound effects on envelope stability or 
resistance to environmental insults. The foremost question is why Hfq —and likely 
sRNAs — would regulate LPS? Quick posttranscriptional regulation mediated via Hfq 
may alter LPS presentation and benefit  the bacterium if the new surface presentation 
diminishes host recognition. In this respect, Hfq functions with sRNAs to effect prompt 
changes in UPEC antigenicity. Alternatively, the LPS alterations in !hfq UPEC may 
make it  more antigenic or disrupt LPS stability, facilitating removal of the pathogen from 
the urinary tract. The latter option is perhaps more plausible considering the significant 
colonization and IBC-formation defects observed in !hfq UPEC.
The next question becomes: “How does Hfq regulate LPS presentation?” The 
mechanism by which Hfq alters the LPS profile is currently unknown, as is how 
abnormal LPS in the hfq mutant relates to the other observed envelope phenotypes. Do 
the alterations to LPS evident in the hfq null UPEC generally  destabilize the envelope, 
leading to the other observed phenotypes, such as reduced motility and sensitivity to 
cationic peptides? Or does misregulation of some prior envelope component or pathway 
lead to LPS abnormality  concomitant to the other phenotypes? In other words, does LPS 
alteration cause or result from any of the envelope deficiencies seen in the hfq null 
mutant? The following are speculations on the matter:
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The altered LPS profile of the !hfq mutant is attributable to aberrant production, 
processing, polymerization of surface sugar molecules or turnover. Production defects 
could result in decreased LPS components (lipid A, core LPS, or O-antigen polymerized 
LPS) at any stage since lack of necessary precursors would be followed by  an absence of 
modified, transported, and polymerized products. Processing and transportation defects 
might resemble O-antigen polymerization defects as they would segregate lipid A and 
core LPS from the polymerization apparatus in the periplasm, resulting in truncated LPS 
of reduced molecular weight. Defects in LPS turnover would manifest  on an LPS profile 
as LPS constituents of the same molecular weight with greater or lesser abundance. The 
hfq mutant LPS profile clearly  showed accumulation of LPS core and lipid A with 
polymerized LPS of reduced molecular weight. This suggests the defect or defects 
responsible are subsequent to production, and may include trafficking of lipid A and the 
core region to the outer membrane, polymerization, or perhaps enhanced degradation of 
long-chain polymerized LPS.
The reduced molecular weight LPS in the !hfq mutant UPEC could also be 
explained by aberrant LPS modification. At least one sRNA, MgrR, regulates LPS 
modification via immediate downstream targets. The Hfq-dependent MgrR sRNA 
represses expression of the Ca2+-induced phosphoethanolamine transferase protein EptB 
(47) (see Fig. 4.3.). EptB adds phosphoethanolamine modifications to LPS (49,50), 
which, if present in E.coli LPS, could serve to increase its molecular mass. Given MgrR 
sRNA translationally inhibits EptB, loss of either Hfq or MgrR should derepress EptB, 
leading to higher molecular weight species of LPS, opposite of observed !hfq LPS 
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profiles. Therefore there must be other sRNAs or Hfq effects responsible for the modified 
LPS observed in the hfq null mutant besides MgrR regulation of LPS modification by 
EptB.
Other sRNAs regulate expolysaccharide and cellulose production, which may be 
represented on an LPS profile. MicA and CyaR are Hfq-dependent sRNAs which 
translationally  inhibit expression of outer membrane protein OmpX (51, 52) (see Fig. 
4.3.). Deletion of Escherichia coli OmpX increases exopolysaccharide (EPS) production 
threefold, whereas overexpression of OmpX has no effect on EPS levels (53). Loss of 
Hfq should result in inability of MicA and CyaR to inhibit ompX translation, the 
consequence being normal or greater OmpX expression. However, the presence of OmpX 
only appears to maintain normal levels of EPS, and even enhanced levels of OmpX have 
no effect on EPS, as noted above (53). So, while MicA and CyaR sRNAs can influence 
EPS levels, the current body  of literature suggests they only have power to increase EPS 
levels through OmpX, not decrease them, as may be seen in the hfq null LPS profile.
As an interesting aside, OmpX assists in virulence for Yersinia pestis and UPEC 
by promoting adhesion to cellular surfaces (92-94). In Escherichia coli, deletion of ompX 
upregulates type 1 pili production dramatically  while reducing motility rates through agar 
(53). My hfq mutant clearly  had reduced motility rates relative to wild type, like an ompX 
mutant, but also reduced type 1 pili, as evidenced by  hemagglutination and cell adherence 
assays (see Chapter 3). Alleviation of ompX repression by the Hfq-dependent sRNAs 
MicA and CyaR in an hfq null mutant would be anticipated to increase motility and 
reduce type 1 pili, although only  one of these is seen. Therefore, the motility  and type 1 
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FIG. 4.3. sRNAs regulating LPS processes. Genes, shown in green, regulated by their 
respective Hfq-dependent sRNAs, shown in white. Affected downstream processes are 
shown in blue. Outer membrane protein (OMP) genes shown in orange. Upstream and 
downstream transcriptional regulators shown in red. Numbers correspond to references.
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pili effects observed in hfq mutant UPEC could not be attributed singularly  to alteration 
of OmpX levels. The possibility for synergistic effects with other misregulations resulting 
from inoperative sRNAs may explain these divergent phenotypes. Additionally, OmpX is 
required for full virulence in mouse and rat models of Yersinia pestis infection, and is 
reliant upon proper length of the LPS core (94). It  is possible that derepression of OmpX 
expression in an hfq null mutant — and anticipated increase in virulence — is 
compensated for by the aberrant LPS profile of hfq mutant UPEC.
Besides regulating EPS through ompX, MicA sRNA also regulates production of 
cellulose, as can the RseX sRNA. Bacterial cellulose is another polymeric sugar which 
may be discerned on an LPS profile. The Hfq-dependent MicA and RseX sRNAs 
translationally  repress expression of ompA, which encodes the outer membrane protein 
OmpA (51, 59) (see Fig. 4.3.). OmpA represses cellulose production via the CpxRA 
system (56, 57). Deletion of ompA produces sticky  colonies due to enhanced cellulose 
production while overexpressed OmpA causes cell lysis (57). Loss of Hfq theoretically 
abrogates ompA repression by MicA and RseX, permitting OmpA translation and OmpA’s 
repression of cellulose production, resulting in loss of cellulose signal on an LPS profile. 
Molecular weight for a polymeric carbohydrate can vary significantly, however, and may 
not appear as a discrete band on an LPS profile at all. Large polymers may be 
unresolvable as a high molecular weight smear or become trapped in the stacking gel. As 
yet, my existing LPS profiles have not differentiated cellulose, and this possibility 
remains to be addressed.
102
103
The role of the abnormal LPS profile of hfq-null UPEC is still an open question. 
Currently known sRNAs are likely not responsible for the aberrant hfq-null LPS profile, 
suggesting novel action by Hfq and other possible sRNAs. Is misregulated LPS 
responsible for the other envelope sensitivities observed, or merely  symptomatic of 
greater aberrations? This could be tested by disrupting genes involved in LPS production, 
polymerization, transport, or turnover and performing LPS profiling to look for mutants 
phenocopying hfq-null UPEC’s profile. A strain phenocopying hfq-null UPEC’s LPS 
profile is an ideal candidate to explore LPS regulation by Hfq. These (and other LPS 
mutants) could be subjected to the same phenotypic assays used to characterize the UPEC 
hfq mutant observing for phenotypic overlap. If LPS mutants exhibited reduced motility, 
sensitivity to cationic peptides, ineffective murine colonization or IBC formation, this 
would signify the epistasis of the LPS alterations to the other observed phenotypes and 
highlight the paramount structural role of LPS in virulence. UPEC have already  proven 
themselves formidable opponents against stresses that normally eliminate traditional lab 
strains of E. coli (95), however, and may be sufficiently resilient to withstand alterations 
to their abundant LPS. In this scenario, LPS mutants mimicking the hfq-null LPS profile 
do not recapitulate the other hfq-null phenotypes, signifying Hfq’s control over other 
cellular processes as responsible for the deficient phenotypes. Many of the LPS 
biosynthesis and transport genes are known and were exploited to produce LPS cores of 
various lengths in Gram negative Yersinia (94). This paves the path for similar studies in 




Structural consequences of OMP misregulation
Alleviation of Hfq-mediated sRNA repression of OMPs may increase baseline 
envelope stress, sensitizing bacterial cells to further stresses. Many Hfq-dependent 
sRNAs translationally repress abundant outer membrane proteins, such as OmpA by 
MicA (14-16, 55) and RseX (59), OmpC by IpeX (63), MicC (55, 62), RybB 17, 51) and 
RseX (59), OmpF by IpeX (63) and MicF (18-20, 66), OmpX by  CyaR (51, 52) and 
MicA (51), and ChiP by MicM  (21). In the absence of Hfq, this repression is alleviated, 
resulting in OMP expression regardless of the regular translational inhibition 
mechanisms. This may result  in activation of the "E pathway, which responds to 
overexpressed or misfolded OMPs by upregulating chaperones and proteases to manage 
these envelope stresses (96). Perhaps not  surprisingly, the "E pathway also exerts 
translational control over OMPs via activation of the CyaR (51), MicA (17, 58), and 
RybB sRNAs (17, 23). The "E pathway thus adjusts OMP levels at the translational and 
posttranslational levels, demonstrating the necessity of OMP abundance control. 
Regulation of OMPs by sRNA appears to be a common mechanistic motif (see 
Fig. 4.4.), which must be of evolutionary significance to the bacterium. If this were not 
the case PTR of OMPs would not be so universal nor common. It is reasonable the loss of 
repression of multiple OMPs simultaneously  may impose an envelope stress of its own, 
which may be sufficient to occupy envelope stress response pathways. Additional stresses 
subsequently  imposed upon this already stressed system then become insurmountable, 
producing the observed sensitivities to polymixin B, RNS, and ROS. This may explain 
the reduced motility of the hfq mutant  as well, as transport or degradation of flagellin 
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subunits is partially compromised by  a system barely able to handle a burden of beta-
barrel OMPs.
Biofilm regulation by sRNAs
The hfq-null UPEC mutant exhibited notable deficiencies in microtiter-plate 
biofilm formation assays. As the body of biofilm literature and continued funding 
evidence, biofilm formation is a multifactorial process involving quorum-sensing, 
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FIG. 4.4. Attributes regulated by PTR in UPEC. Green arrows indicate upregulation or 
activation while red arrows indicate inhibition.
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production of exopolysaccharides, cellulose, and other extracellular matrix materials 
(97-104), the full extent of which is incompletely understood. Except  for E. coli quorum 
sensing, all of these processes are regulated by  Hfq-dependent sRNAs, possibly 
explaining reduced pathogenicity and biofilm formation in hfq-null UPEC.
Extracellular polysaccharides or exopolysaccharides (EPS), and cellulose are 
common bacterially-produced biofilm constituents (57, 103-105). Biosynthesis of EPS 
and cellulose are processes regulated by Hfq-dependent sRNAs (see Fig 4.4.). EPS 
biosynthesis is repressed by OmpX (53), and OmpX is repressed by the Hfq-dependent 
sRNAs CyaR (51, 52) and MicA (51). Cellulose production is inhibited by OmpA (56, 
57) which is itself repressed by the Hfq-dependent sRNAs MicA (14, 15, 55), and RseX 
(59). Loss of Hfq should alleviate repression by these sRNAs and enhance expression of 
OmpX and OmpA, inhibiting EPS and cellulose production. This may answer how hfq-
deleted UPEC produce reduced mitrotiter plate biofilms and may account for the reduced 
IBCs seen in vivo.
Also of note, MicA promotes both EPS and cellulose biosynthesis through 
repression of inhibitors to these pathways and is required for Salmonella enterica serovar 
Typhimurium biofilm formation (106). However, of all the sRNA mutants affecting OMP 
expression, LPS modification, motility, piliation, or curli production, only loss of MicA 
sRNA has shown any sensitivity to envelope stress (54). This strongly suggests MicA 




Curli are extracellular amyloid-like fibrils which assist biofilm formation when 
expressed (101, 102, 107). DsrA sRNA regulates biofilm formation indirectly via the 
RcsAB pathway. When overexpressed, DsrA derepresses translation of rcsA, through an 
indirect mechanism involving the histone-like protein HNS (80). The rcsA gene encodes 
a component of the RcsAB transcriptional factor, which represses the curli biosynthesis 
operon csgDEFG (83), and as a side-note, the master regulator of motility, flhDC (86, 
108). While DsrA expression indirectly  represses transcription of the csgDEFG operon 
via the RcsAB transcription complex, two sRNAs directly inhibit translation of the 
operon. The highly homologous sRNAs, OmrA and OmrB, bind the 5’ end of the 
csgDEFG transcript, inhibiting its effective translation (87) in an Hfq-dependent manner 
(67). The csgDEFG operon is thus regulated at  both the transcriptional and translational 
levels by processes involving sRNAs. BLAST searches reveal the genomic presence of 
DsrA, OmrA, and OmrB in UPEC. Loss of Hfq, and concomitant function of the sRNAs 
DsrA, OmrA, and OmrB, would predictably  result in upregulation of the curli 
biosynthesis operon. However, the hfq mutant UPEC mutant evidenced lower abundance 
of polysaccharides, with those present having decreased molecular weights. Thus the LPS 
profile seen cannot be attributed to the sRNAS DsrA, OmrA, or OmrB.
UPEC: The "E mutant that lived
In the course of studying Hfq effects on the virulence and fitness in UPEC, I 
generated a viable rpoE mutant as a control. The alternative sigma factor, "E, coded for 
by the rpoE gene, responds to heat-shock and misfolded outer membrane proteins 
(OMPs) by  upregulation of periplasmic folding and degradation factors (109, 110). In 
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addition to these protein factors, sRNAs are upregulated that quickly  inhibit translation of 
OMP transcripts (30, 31). OMPs are some of the most abundant bacterial proteins, and 
maintenance of appropriate OMP levels while avoiding their misfolding is a survival 
imperative. It comes as no surprise, therefore, that "E is considered an essential factor in 
K12 E.coli laboratory strains (111). However, second-site suppressor mutations have 
been isolated which permit deletion of rpoE in these strains (112).
So why then is an rpoE mutant in UPEC viable? The answer may lie in the 
accessory  sequestration factors that are cotranscribed with rpoE. In UPEC, I generated a 
viable rpoErseABC deletion mutant, rather than deleting the rpoE gene individually (see 
Chapter 3). Although rseABC are co-transcribed with rpoE, there is an independent "E -
type promoter downstream of rpoE (113, 114). The rseABC gene products, RseA and 
RseB, operate as anti-"E factors, sequestering "E at the inner membrane under non-
inducing conditions (113). RseC assists reducing members of the SoxR reducing complex 
(115), and also promotes "E activity through an unknown mechanism (113).
I deleted rseA, rseB, and rseC simultaneously with rpoE for cloning convenience 
under the assumption that they would not be required due to loss of "E. The resulting 
mutant was viable, growing equivalent to the parental strain in shaking LB broth cultures, 
although it was significantly  defective in resisting RNS and ROS. To address the 
possibility of secondary-site suppressor mutations permitting deletion of rpoE, I 
successfully  trans-complemented the mutant with the entire rpoErseABC operon, 
restoring the wild type phenotypes. This implies that deletion of rpoE in UPEC is viable 
because 1) the expression of the rseABC genes is toxic in the absence of "E or 2) UPEC 
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possess some intrinsic difference relative to the K12 strains that permits disruption of 
rpoE.
Regarding the first possibility, deletion of rseA results in upregulation of "E 
activity (113, 116), while rseB deletion produces only marginal activation in non-
inducing conditions and no change in "E-inducing conditions (116). Loss of rseC results 
in constitutive expression of oxidative stress responsive transcriptional activator soxS 
(115). SoxS then activates a network of genes involved in resistance to antibiotics 
(117-119), superoxide (120-122), organic solvents (123, 124), and heavy metals (125). 
Thus an rseC mutant might be anticipated to have a greater abundance of resistance 
proteins for antibiotics, superoxide, organic solvents and heavy metals. However, my 
work has demonstrated the lack of resistance to oxidative stress in the UPEC 
rpoErseABC mutant (126) despite anticipated constitutive activation of soxS. This seems 
to argue against the viability  of !rpoErseABC UPEC hinging upon concomitant deletion 
of rpoE and rseC.
While envelope maintenance in K12 E.coli is dependent upon "E, it appears that 
UPEC may have redundant envelope maintenance capabilities, or perhaps not suffer the 
same degree of incipient envelope stress as laboratory  strains. This latter possibility hints 
at additional UPEC factors enabling its survival. Interestingly, second-site mutation of the 
hypothetical gene ydcQ, of K12 E. coli, permits deletion of rpoE (112). BLAST 
alignments indicate this region contains a deletion in multiple UPEC strains, possibly 




The possibility also exists the original study characterizing "E as absolutely 
required was flawed. Prior studies determined the necessity of "E in K12 E.coli by non-
targeted transposon mutagenesis (109-111, 127). Because rpoE lies upstream of rseABC, 
and can be contranscribed with them (113, 114, 128), it is possible the introduction of a 
transposon eliminates or otherwise alters transcription of the downstream rseABC genes. 
Forseeably, upregulation of the rseABC genes is possible. The possibility  again becomes 
that expression of RseA, RseB, or RseC is toxic and follows the same analysis given 
several paragraphs prior. The overexpression scenario seems particularly  unlikely, 
however, as SoxS upregulation should result in cells more resistant to oxidative and 
antibiotic stresses, not less, as observed in the UPEC rpoErseABC mutant.
Complicity of Hfq and CsrA
In a curious twist of regulatory fate, CsrA and Hfq regulate one another. Baker et 
al. have demonstrated CsrA binding to the hfq leader region inhibits hfq translation in 
Escherichia coli (129). Hfq also negatively  regulates its own translation (130). 
Oppositely, the Hfq homolog in Legionella pneumophila upregulates csrA gene 
expression through an unknown mechanism (131). This suggests an interesting 
autoinhibitory loop whereby  Hfq upregulates CsrA, eventually  downregulating Hfq. This 
regulatory loop may  imply a chronological cycle or hierarchy  of PTR activity in which 




In the context of UPEC infection, speculative scenarios come to mind in which 
colonizing bacteria immediately respond to environmental changes and host  innate 
immune defenses through fast-acting sRNA-mediated methods, enabling the pathogens to 
survive. They later switch to CsrA-mediated PTR to activate glycolysis and motility to 
spread. This may involve temporal-spatial changes in CsrA and Hfq activity throughout 
the various phases of infection: attachment, invasion, IBC-formation, efflux and 
dissemination or ascension (see Fig. 4.1.). The fact that both varieties of PTR function 
rapidly may  also suggest they both function at every  step  of infection as new 
environments and insults are encountered, with Hfq/sRNAs quickly readapting the 
bacterium to immediately cope with the stress and CsrA dictating lifestyle choices of 
whether to form biofilms or opt for motility. Lastly, it is possible that this regulatory loop 
represents a constant fine balance of background activities lacking major temporal-spatial 
fluctuations. Hfq and CsrA individually represent systems of incredible complexity, and 
their complicity in UPEC pathogenesis needs to be addressed.
Interplay between Hfq and CsrA is further suggested by their shared and unique 
phenotypes. Both PTR systems regulate motility and biofilm formation (see Fig. 4.4.). 
Both Hfq and CsrA positively regulate motility, as evidenced by the reduced motility of 
the hfq mutant UPEC and the known role of CsrA upregulating the FlhDC master motility 
regulator (26). Although the methods CsrA upregulates motility are well characterized, 
the pathway for Hfq control of motility is more speculative. The Hfq-dependent sRNA, 
DsrA, posttranscriptionally represses hns, coding for the nucleoid protein H-NS (80). H-
NS exerts transcriptional activity, simultaneously promoting translation of the flhDC 
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master regulator of motility (132) and downregulating expression of rcsAB (83), which 
represses flhDC expression (85, 86) (see Fig. 4.3.). In short, Hfq promotes motility 
coordinately with DsrA, and loss of Hfq should result in inability  of DsrA to repress hns, 
resulting in repression of motility. Although hfq-deleted UPEC were motile, they were 
significantly impaired in motility rate. So, both Hfq and CsrA function to promote 
motility. 
While both Hfq and CsrA regulate biofilm production, they do so antagonistically. 
CsrA is known to inhibit biofilm elaboration in K12 laboratory  strains of E.coli, and a 
!csrA mutant readily  forms biofilms on glass (27, 133). Similarly, a UPEC !csrA mutant 
forms massive biofilms and seemingly grows slower and to a lower density than the 
parental wild type strain at 30º and 37ºC in LB broth and M9 minimal media. Growth of 
this mutant also yields thick mucus-like material at the air-fluid interface in glass tubes, 
but forms non-attached cellular aggregates in plastic tubes or microtiters plates. While 
presence of CsrA represses biofilm formation, Hfq promotes it, as hfq deletion resulted in 
significantly reduced microtiter-plate biofilms, IBCs, and no observable non-attached 
cellular aggregates (see Chapter 3). Thus, Hfq and CsrA differentially  impact biofilm 
formation as evidenced by microtiter plate biofilm assays.
Considering possible cross-regulation of Hfq and CsrA, a hierarchical set  of 
responses in which Hfq assists in biofilm formation and stress adaptation precede escape 
by motility, as CsrA becomes activated, is plausible. Given the specific regulation of hfq 
translation by CsrA (129), it is possible that some of the phenotypes observed in csrA-
deleted UPEC result  from enhanced Hfq production. This does not appear to be the case, 
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however, considering the apparent  growth defects of the !csrA-deletion strain. The 
predicted upregulation of Hfq, and subsequent sRNA-mediated PTR in a csrA-null strain 
does not overcome the general decrease in fitness this mutant exhibits. Thus, while CsrA 
and Hfq are known to regulate each other in different organisms, these interactions and 
their functional consequences still need to be addressed in UPEC.
Another interesting connection implied by my work with Hfq and CsrA PTR 
systems is cross-regulation of "E. Hfq indirectly downregulates "E activity  (22, 134, 135). 
This complex regulation involves multiple factors, such as DegS, the periplasmic 
protease responsible for degradation of the RseAB "E-sequestration complex, which is 
significantly increased in an hfq-deletion mutant (135). In addition, expression of the 
Hfq-dependent sRNA, RybB, is dependent upon, and downregulates, "E translation, 
providing a "E autoregulatory loop  (17, 23). While sRNAs and Hfq downregulate "E, the 
Cpx pathway transcriptionally  activates "E expression through the response regulator 
CpxR (136). Given the downregulatory  effect of CsrA upon CpxP under nitrosative 
stress, CsrA may  indirectly influence "E activity. Downregulation of CpxP by CsrA may 
result in activation of the Cpx pathway, which in turn upregulates "E. In this respect, the 
protein-mediated and sRNA-mediated classes of PTR may function antagonistically to 
one another with respect to "E. Downregulation of CpxP by CsrA under nitrosative stress 
is enigmatic, however, and it is not clear that RNS-mediated ablation of CpxP expression 
actually leads to increased Cpx pathway activation. Consequently, while it is possible that 
PTR by CsrA upon CpxP may affect "E, this remains to be tested.
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Importance of PTR in UPEC
This study has demonstrated the unique roles of both CsrA-mediated and Hfq-
mediated PTR regulating UPEC virulence by investigating chemical resistance and 
murine infection phenotypes in gene deletion mutants. Specifically, PTR regulation 
involving Hfq is dispensable for in vitro growth but is critical for infection in murine 
models of cystitis and pyelonephritis. My in vitro analyses clarify  Hfq’s requirement in 
resisting a variety of insults a host  may present. Thus, Hfq is a key  regulator of stress 
responses contributing to UPEC survival in adverse conditions, including life within a 
host.
CsrA, on the other hand, is required for normal in vitro growth of UPEC, although 
its activity  may be detrimental under nitrosative stress by downregulating the periplasmic 
chaperone CpxP. In vitro CpxP overexpression proved beneficial under nitrosative stress, 
suggesting that downregulation of CpxP is an effect of host-supplied RNS limiting 
bacterial growth. However, I cannot rule out the possibility  that this phenomenon serves 
another as-yet undefined purpose that  may actually benefit the pathogens in the end. 
Downregulation of CpxP in the presence of RNS may be attributed to nitration of CsrA 
and may represent the first evidence of posttranscriptional regulation by nitration in 
Escherichia coli.
Besides demonstrating the importance of PTR in UPEC virulence, these 
discoveries raise additional questions. Regarding nitrated CsrA, the question remains if 
nitrated CsrA actually binds the 5’ UTR of the cpxP transcript, or if it exerts control 
indirectly. Binding parameters for nCsrA still need to be ascertained. Does nCsrA still 
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bind RNA, and if so, are its binding parameters altered by  nitration? If RNA 
immunoprecipitation or footprinting analyses do confirm nCsrA RNA-binding activity, 
affinity studies can address if nCsrA has a novel binding consensus region. These data 
could subsequently lead to predictions of other RNA targets of nCsrA.
The discovery that Hfq influences UPEC pathogenesis strongly suggests sRNAs 
are involved in these regulations. The foremost question is which specific sRNAs are 
responsible for the pathogenicity defects observed in the hfq mutant? Gene deletion 
mutants for specific sRNAs may  mimic a subset of conditions present in the hfq 
knockout, permitting association of particular sRNAs with observed hfq-null phenotypes. 
Such a study could not account for novel or UPEC-specific sRNAs which may  be 
responsible for these phenotypes, however. Addressing this possibility requires much 
more involved methods, such as differential expression analyses or custom genome-tiling 
microarrays of UPEC during in vivo murine infection versus UPEC grown in vitro. Any 
sRNA or expressed intragenic regions could be deleted or overexpressed and subjected to 
the panoply of phenotypic assays assembled to assess hfq mutant UPEC.
The hfq-null UPEC mutant’s phenotypes may be broadly characterized as 
envelope deficiencies and previously  discussed the possibility that gross alterations to 
OMP expression or LPS misregulation may either contribute to or arise from the 
perturbed envelope. The genes coding for OMPs, OMP transport and assembly  proteins, 
and LPS biosynthesis are well characterized. Tunable overexpression of multiple OMPs 
simultaneously  or simultaneous deletion of the CyaR, MicA, RseX, RybB, MicC, IpeX, 
and MicF sRNAs regulating OMPs (14, 15, 17, 19, 51, 52, 55, 59, 62, 63, 66) may yield 
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UPEC phenocopying the hfq mutant, indicating the envelope deficiencies result from 
overloaded envelope stress response pathways. Similarly, if LPS biosynthesis deletion 
UPEC mutants produce the same sensitivities as the hfq mutant, these observations would 
support a model of LPS as a critical structural component  whose alteration produces 
envelope sensitivity. Bioinformatics predictions would then help align putative sRNAs 
with known LPS biosynthesis genes to find potential regulatory sRNAS.
Another remaining question is how important is the MicA sRNA in UPEC 
pathogenesis? MicA regulates both ompX (51) and ompA (14, 15, 55), and thus EPS 
elaboration (53) and cellulose production (56, 57).  MicA is required for biofilm 
formation in bacterial “cousin” Salmonella enterica serovar Typhimurium (106), and of 
all the OMP-regulating sRNAs, only deletion of MicA produces any envelope sensitivity 
(54). MicA thus seems an ideal sRNA candidate for biofilm regulation in UPEC, although 
its role in IBC formation or in vivo infection has yet to be assessed.
Of the questions raised in this study  perhaps the most intriguing is how and why 
Hfq and CsrA interregulation occurs. Consider the critical importance of both Hfq and 
CsrA in UPEC virulence phenotypes demonstrated in this work, the role of this reciprocal 
regulation in the context of UPEC virulence is a tantalizing lead. Is there, in fact, a cycle 
of regulation oscillating between Hfq- or CsrA-dominated modes? If so, does this cycle 
decide  motile or cessile lifestyles for UPEC? Expression studies of CsrA, CsrB, and Hfq 
in UPEC during infection of tissue culture or mouse bladders performed at high temporal 
resolution would begin to reveal any  such cycle, or perhaps demonstrate expression 
patterns for either as UPEC progresses through infection.
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This work links PTR of both the protein-mediated and sRNA-mediate varieties in 
regulation of specific UPEC virulence determinants and demonstrates the significance of 
both during in vivo murine infections. Many of the phenotypes resulting in abrogation of 
UPEC’s PTR mechanisms resulted in envelope sensitivities, and while Hfq is known to 
regulate the SigmaE envelope stress response pathway, this work has shown regulation of 
the Cpx envelope stress response pathway by CsrA. Significantly, this demonstrates 
regulation of the two principle envelope stress response pathways by PTR, suggesting 
rapid translation regulation of envelope stress pathways is of great benefit to UPEC, 
particularly during infection. Not only has this study  demonstrated PTR is required for 
proper envelope responses in UPEC, but, specifically  in the case of CsrA, may also be a 
target of host innate immune responses. If the host modulates UPEC virulence via PTR 
mechanisms, this may represent a novel and exploitable means of pathogen control via 
targeting envelope stress response pathways. This gateway research has opened numerous 
avenues and opportunities for future pathogenesis research specifically  regarding 
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